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ABSTRACT OF DISSERTATION

IDENTIFICATION AND CHARACTERIZATION OF SOCS44A IN DROSOPHILA

The JAK/STAT pathway is but one of the signal transduction cascades
responsible for proper development and homeostasis. Gain-of-function mutations of
pathway components are causative agents of several leukemias, highlighting the necessity
for proper regulation of signal transduction. Drosophila presents an attractive model to
study JAK/STAT signaling because mutations in the pathway behave in an analogous
manner. Furthermore, the Drosophila cascade is much simpler as only one of each
component required for activation has been characterized; whereas in mammals, there are
many ligands, receptors, 4 JAKs and 7 STATs.
Suppressors of Cytokine Signaling (SOCS) are one family of molecules which
regulate JAK/STAT signaling via a negative feedback loop. All SOCS share a distinct
modular domain architecture, which we exploited to locate three putative SOCS
homologues within the Drosophila genome. I present the identification and initial
characterization of one of these homologues, Socs44A. I show that Socs44A is not
responsive to or dependent on JAK activity. However, I demonstrate that Socs44A is
capable of downregulating JAK/STAT signaling in the developing wing but not in

oogenesis, indicating that its ability to regulate the pathway is tissue specific, a
phenomenon observed in the mammalian model.
Signal transduction pathways are integrated at multiple levels. This interplay
allows for combinatorial signaling, resulting in a higher order of complexity in the signals
that can be received and interpreted by a cell. Well documented are the interactions
between the JAK/STAT and the EGFR/MAPK pathways. In this work, I show that
Socs44A can genetically interact with, and upregulate, the EGFR/MAPK pathway,
analogous to a recent report involving SOCS-3.
Starting with the Drosophila genome sequence, I initiated a reverse genetic
approach to studying the function of the Socs44A locus. During the course of this
investigation, I designed and implemented a novel post-processor of the BLAST
algorithm, called Multi-BLAST, which facilitates retrieval of multiple domain sequences
from public databases. In what would have been the ultimate achievement of this study, I
attempted two mutagenesis screens designed to isolate Socs44A loss-of-function alleles.
Progress on these screens is reported.
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Chapter I
Background
General signal transduction
Cell to cell communication is essential for the orchestrated chain of events leading
to proper development of multicellular organisms. Not only must each cell be cognizant
of its location, but it must also have the competence to differentiate into the proper cell
type. This is accomplished through the utilization of signal transduction cascades, which
allow cells to send, receive and respond to extracellular signals. Each cell then must be
able to correctly interpret and integrate all of the signals it receives in order to behave
properly during the course of development.
Surprisingly, there are relatively few signal transduction cascades compared to the
number of tasks they must perform during development and homeostasis. This disparity
is overcome by the fact that each cascade can produce multiple cellular responses by
modulating either the amplitude or duration of their signal. Higher levels of complexity
can be achieved if the integration of multiple signals from multiple cascades is
considered. Finally, the cellular context in which a signal is received also contributes to
the complexity of signaling.
The largest class of signal transduction cascades are those that have a cell surface
receptor, which include the Transforming Growth Factor β, Receptor Tyrosine Kinases,
Notch, Wingless, and the JAK/STAT pathways (for reviews, see Dierick and Bejsovec,
1999; Nilson and Schupbach, 1999; Rawlings et al., 2004; Schweisguth, 2004; Shi and
Massague, 2003). While these cascades are distinct in the particular signals they
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recognize, they behave in a similar fashion. A cell surface receptor (or receptors) comes
into contact with its ligand, resulting in activation of the pathway. The signal then may
be propagated and/or amplified by intermediates and/or second messengers before
reaching the nucleus, where target gene expression is either increased or decreased.

The JAK/STAT signal transduction cascade
In vertebrates, the JAK/STAT (Janus Kinase/Signal Transducer and Activator of
Transcription) signal cascade is an integral intracellular response mechanism involved in
many essential biological processes including cell proliferation, differentiation, and
apoptosis (reviewed in Igaz et al., 2001; O'Shea et al., 2002). Furthermore, the
JAK/STAT cascade is utilized in many tissues in multiple stages of development.
Discovered about 15 years ago, this pathway has been shown to be responsive to a wide
array of extracellular ligands, including interferons, interleukins, growth hormone, and
erythropoietin (see reviews by Imada and Leonard, 2000; Rawlings et al., 2004;
Schindler, 1999; Yeh and Pellegrini, 1999) in addition to some receptor tyrosine kinases,
including epidermal growth factor receptor (EGFR) and platelet derived growth factor
receptor (PDGFR). Due to its virtual omnipresence in development, abnormal
JAK/STAT signaling often leads to deleterious, if not lethal effects, with the majority of
these being defects in hematopoiesis (reviewed in Bowman et al., 2000; Coffer et al.,
2000; Ward et al., 2000). Severe combined immunodeficiency (SCID) is the result of
improper differentiation of lymphocytes. This differentiation is dependent on the
JAK/STAT cascade; patients with SCID have been found to have mutations in either the
shared interleukin receptor gamma chain or JAK-3 (Leonard, 1996). Conversely, the
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fusion of JAK-2 to the TEL ETS transcription factor is but one clinical example that
results in constitutive pathway activity. The consequence is either chronic myeloid
leukemia (CML) or acute lymphoblastic leukemia (ALL), the most prevalent childhood
form of the disease (Ho et al., 1999; Lacronique et al., 1997; Peeters et al., 1997).
Additionally, these leukemias have been reported in patients where STATs are
constitutively activated, although a direct causal link has not been established (GouilleuxGruart et al., 1996).
The JAK/STAT pathway is a simple cascade, in which extracellular signals can
be rapidly transduced to the nucleus to elicit a cellular response in the form of altered
transcription of target genes (Fig. 1-1). The pathway is initiated by ligand induced
dimerization or multimerization of transmembrane receptors. While these receptors have
no intrinsic catalytic activity, they are constitutively associated with a family of tyrosine
kinases, the Janus Kinase (JAK) proteins. Dimerization of the receptors juxtaposes their
associated JAK proteins, allowing the JAKs to transphosphorylate and activate each
other. Activated JAKs also phosphorylate tyrosine residues on the receptors, providing
docking sites for SH2 domain containing molecules, such as STAT (Signal Transducer
and Activator of Transcription). STAT molecules are latent, cytosolic transcription
factors, that when bound to the receptor, can be phosphorylated by the JAK proteins.
Activated STATs can homo- or hetero-dimerize and translocate to the nucleus where they
directly bind DNA and modulate transcription of target genes.
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The JAK/STAT pathway in Drosophila melanogaster
The JAK/STAT pathway is conserved across many species, even insects;
however, Drosophila melanogaster is the only invertebrate model organism that
possesses a complete JAK/STAT pathway that functions similarly to what is found in
mammals (Barillas-Mury et al., 1999; Hombria and Brown, 2002; Rawlings et al., 2004;
Zeidler et al., 2000). Although C. elegans and D. discoidium both possess STAT-like
molecules, they lack JAK homologues and they use STATs in a different manner than do
higher eukaryotes (Dearolf, 1999; Kawata et al., 1997). Because of its relatively
simplistic version of the JAK/STAT pathway, and the powerful tools for genetic
manipulation that the species offers, we have chosen to study JAK/STAT signaling in
Drosophila.
The JAK/STAT pathway was discovered in Drosophila through the molecular
characterization of the hopscotch gene, which was recovered in a screen for maternal
effect lethal mutations and shown to have defects in embryonic segmentation (Binari and
Perrimon, 1994; Perrimon and Mahowald, 1986). Interestingly, the other two wellcharacterized components of the pathway in flies, Stat92E and unpaired, were identified
based on the fact that they share this same embryonic segmentation defect (Harrison et
al., 1998; Hou et al., 1996). The receptor for the cascade, domeless, was identified in two
separate screens, one was looking for mutants with posterior spiracle defects (Brown et
al., 2001), the other isolated the same gene in a screen for suppressors of upd
misexpression in the eye (Chen et al., 2002a). While hopscotch and Stat92E both share
specific sequence similarity to their mammalian counterparts, both unpaired and
domeless are unlike any specific cytokine or cytokine receptor, respectively.
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As in mammals, the Drosophila JAK/STAT pathway is involved in a broad array
of biological processes. In addition to its roles in embryogenesis, the pathway is
responsible for follicle cell fate decisions in oogenesis (McGregor et al., 2002; Xi et al.,
2003), proliferation of larval hematopoietic lineages (Luo et al., 1997), the formation of
larval melanotic tumors, and hypertrophy of larval lymph glands (Harrison et al., 1995).
Furthermore, the JAK/STAT pathway has also been implicated in sex determination
(Jinks et al., 2000), multiple processes in eye development (Luo et al., 1999; Zeidler et
al., 1999), wing vein formation (Yan et al., 1996a), stem cell maintenance during
spermatogenesis (Brawley and Matunis, 2004; Kiger et al., 2001; Tulina and Matunis,
2001), and patterning of other adult structures (Harrison et al., 1995; Zeidler et al., 2000).

Regulation of signal transduction
During development, cells must receive and respond to a variety of signals, many
of which utilize the same signal cascade. Furthermore, a single signal can elicit a variety
of responses; the cell must be able to correctly interpret each signal, or combination of
signals, and produce the appropriate response. To achieve this, a signal cascade must be
tightly regulated with mechanisms to both activate and deactivate the pathway. Negative
regulation of a signal transduction pathway may serve to modulate amplification and thus
change the response to a signal, or return the cell to a “reset” state such that it can
respond to future signals.
Recent studies have revealed several protein families that regulate the JAK/STAT
cascade in several different ways; they include SH2-Bβ, StIP, SHP, PIAS, and SOCS
(Fig. 1-2). Both SH2-Bβ and its relative APS interact with JAK, but have opposing roles.
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SH2-Bβ is a potent activator, while APS negatively regulates JAK activity (O'Brien et al.,
2002). StIP (STAT interacting protein) is a WD40 repeat protein that preferentially
interacts with unphosphorylated STAT in addition to activated JAK. It is believed that
this protein acts as a scaffold in the recruitment of STAT to the receptor complex
(Collum et al., 2000). The SHP (SH2 domain containing phosphatase) family represents
a logical means to downregulate the phosphorylation-dependent JAK/STAT cascade
since phosphorylation is a rapid and easily reversible protein modification. SHP-1 has
been shown to bind to the tyrosine phosphorylated erythropoietin receptor and
dephosphorylate JAK2 (Jiao et al., 1996). The PIAS (Protein Inhibitor of Activated
STAT) family was identified in a two-hybrid screen for proteins that interact with STAT
proteins. PIAS-1 serves as a mechanistic paradigm of this family of proteins; it binds to
activated STAT-1, the resulting complex is unable to bind DNA. Interestingly, it seems
as though each member of the PIAS family interacts with a specific STAT target (Chung
et al., 1997; Liu et al., 1998).

The Suppressors of Cytokine Signaling (SOCS)
The largest and perhaps most versatile family of JAK/STAT negative regulators is
the SOCS (suppressor of cytokine signaling) family, with eight mammalian members
identified. Three different groups identified the SOCS family of genes concurrently, each
giving a different name to their find. Starr and Hilton identified SOCS-1 by virtue of its
ability to suppress interleukin-6 induced macrophage differentiation of M1 cells (Starr et
al., 1997). Yoshimura’s lab utilized a two-hybrid strategy using the kinase domain of
JAK-2 as bait. They isolated a protein that they named JAB (JAK binding protein) and
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illustrated that it reduces the tyrosine-kinase activity of JAKs and suppresses the tyrosine
phosphorylation and activation of STATs (Endo et al., 1997). Finally, Kishimoto’s group
isolated a protein they named SSI-1 (STAT induced STAT Inhibitor) based upon its
immunocrossreactivity to the SH2 domain of STAT-3 and showed that it inhibited the
signaling of a variety of cytokines. Furthermore, they showed that SSI-1 transcription
was induced by interleukin-4 and interleukin-6 (Naka et al., 1997). Two years prior to
these discoveries, Yoshimura’s group isolated CIS (Cytokine Inducible Suppressor), a
novel gene that was able to inhibit signaling through the Epo and several interleukin
receptors and showed that CIS was induced by several cytokines (Yoshimura et al.,
1995). In the interest of clarity, we will refer to all of these mammalian genes as SOCS-1
to SOCS-7 and CIS (Table 1-1).
All SOCS proteins possess a similar structure; in addition to a central SH2
domain, these genes also contain a carboxy-terminal motif, termed the SOCS box, as well
as an undefined amino terminal region of variable length. The SOCS box is
approximately forty amino acids in length and has been found by sequence homology in
twenty different proteins belonging to five structural classes (Hilton et al., 1998). Each
class is delineated by the identity of the central domain, be it an SH2 domain (SOCS),
SPRY domain (SSB), WD-40 repeat (WSB), ankyrin repeat (ASB) or undefined motif.
Current studies in mammals have shown that SOCS proteins may downregulate
the JAK/STAT pathway in several ways (Fig. 1-1). All SOCS proteins contain an SH2
domain, which allows for interaction with phosphotyrosine activated components of the
JAK/STAT pathway (for review of the SH2 domain in signaling, see Yaffe, 2002).
Beyond this, explicit mechanisms of action must be implied from biochemical analyses.
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SOCS-1 has been shown to associate directly with all four mammalian JAKs, acting as a
pseudosubstrate, inhibiting their catalytic activity (Endo et al., 1997; Naka et al., 1997;
Nicholson et al., 1999; Yasukawa et al., 1999). Unlike SOCS-1, CIS does not interact
directly with JAKs; instead, CIS associates with the activated Epo receptor at one of two
STAT-5 binding sites (Verdier et al., 1998) and competes with STAT-5 for binding to the
receptor (Matsumoto et al., 1999). SOCS-3, unlike SOCS-1, does not inhibit JAK-1 or
JAK-2 catalytic activity via in vitro kinase assay (Nicholson et al., 1999); and unlike CIS,
it does not compete with STAT-5 (Ram and Waxman, 2000). However, it does possess a
sequence resembling a JAK activation loop similar to SOCS-1 (Yasukawa et al., 1999)
and it can bind JAK-1, albeit with a much lower affinity than SOCS-1 (Nicholson et al.,
1999). Furthermore, SOCS-3 has been shown to bind to the gp130 cytokine receptor
subunit (Nicholson et al., 2000), IL-2Rβ receptor (Cohney et al., 1999), and GH receptor
(Hansen et al., 1999). Taken together, these observations suggest that SOCS-3 inhibits
JAK/STAT signaling by a different mechanism than SOCS-1 or CIS. Finally, the
carboxy-terminal SOCS box has been shown to interact with the elongin BC complex, an
interaction that is inhibited by tyrosine phosphorylation of two residues within the SOCS
domain (Haan et al., 2003). The Elongin BC complex also interacts with an E3 ubiquitin
ligase (cullin-2) that could target bound proteins for proteosomal degradation (Fig. 1-3). .
Thus, the SOCS proteins could act as adaptors whose role would be to couple activated
JAK/STAT constituents to this elongin BC complex, ultimately leading to their
ubiquitination and degradation (Kamura et al., 1998; Zhang et al., 1999).
Phenotypically, SOCS genes parallel what is seen in other JAK/STAT molecules
(Table 1-1). Targeted knockouts of SOCS-1 produce runted mice that die at three weeks
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of age, suffering from severe reduction in platelet and hematocrit cells, fatty degeneration
of the liver and macrophage infiltration of major organs (Alexander et al., 1999; Marine
et al., 1999b; Metcalf et al., 1999; Naka et al., 1998; Starr et al., 1998). This is
reminiscent of the phenotype seen when IFNγ is administered to neonatal wild-type mice
(Gresser et al., 1981). Transgenic mice that overexpress SOCS-3 do not survive to birth
(Marine et al., 1999a), but have a phenotype that resembles that of JAK-2-/- mice
(Neubauer et al., 1998; Parganas et al., 1998). Mice lacking SOCS-2 grew significantly
larger than their wild-type littermates; a result from deregulated growth hormone (GH)
and insulin-like growth factor-I (IGF-I) signaling (Metcalf et al., 2000).
Very little is known about the remaining four SOCS (SOCS-4 to SOCS-7).
Recently, a knockout of SOCS-6 was created; however, these animals showed only mild
growth retardation (Krebs et al., 2002). Biochemical analyses suggest that SOCS-6 may
regulate insulin signaling (Krebs et al., 2002; Mooney et al., 2001). A single report
indicates that overexpression of SOCS-5 disrupted Th2 cell differentiation in culture
(Seki et al., 2002). However, a recently developed knockout of the gene had neither no
visible phenotype save a mildly increased erythropoiesis, nor did its absence affect T cell
differentiation (Brender et al., 2004). To date, there are no functional studies of either
SOCS-4 or SOCS-7.
Data mining of the Drosophila genome has produced three putative SOCS
homologues (Adams et al., 2000). Based on their inferred cytological location on
polytene chromosomes, we named these homologues Socs16D, Socs36E, and Socs44A.
Of these, Socs36E is the most studied; it shares similar embryonic and ovarian patterns of
expression to Unpaired. Furthermore, it shares misexpression phenotypes consistent with
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a role in negatively regulating the JAK/STAT pathway (Callus and Mathey-Prevot, 2002;
Karsten et al., 2002 and Rennebeck, unpublished). This work will focus on the molecular
and functional characterization of Socs44A. This study examines its roles in Drosophila
development and its functions in JAK/STAT signaling. Furthermore, we will discuss the
discovery of an interaction between Socs44A and EGFR signaling.
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Figure 1-1. Activation of JAK signaling and subsequent inhibition by SOCS
proteins. Ligand binding induces receptor dimerization and pathway activation
propagated by tyrosine phosphorylation of Janus Kinase (JAK) and Signal Transducer
and Activator of Transcription (STAT) intermediates. Activated STATs can dimerize,
translocate to the nucleus and control transcription of target genes, including SOCS
(Suppressor of Cytokine Signaling). SOCS can then act to inhibit JAK signaling by a
variety of mechanisms. See text for more details.
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Figure 1-2. Regulators of JAK/STAT signaling. Positive regulators are labeled in
green, while negative regulators are labeled in red. Both SH2-Bβ and its relative APS
interact with JAK, but have opposing roles; SH2-Bβ is a potent activator, while APS
negatively regulates JAK activity. StIP preferentially interacts with unphosphorylated
STAT in addition to activated JAK, acting as a scaffold in the recruitment of STAT to the
receptor. The SHP family represents a logical means to downregulate the
phosphorylation-dependent JAK/STAT cascade since phosphorylation is a rapid and
easily reversible protein modification. The PIAS family binds to activated STATs and
this complex is unable to bind DNA.
12

Figure 1-3. Model for SOCS mediated proteosomal degradation of JAK. The SH2
domain allows SOCS proteins to interact with activated components of the JAK/STAT
pathway. The SOCS box interacts with the elongin BC complex, which in turn interacts
with cullin-2, an E3 Ubiquitin ligase. Roc1 is a RING finger protein that recruits the E2
Ubiquitin conjugating enzyme to the ligase complex (Furukawa et al., 2003; Furukawa et
al., 2002). The resulting polyubiquitination of the activated component labels it for
degradation by the proteosome.
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Table 1-1. The SOCS family of proteins: interactions, regulation, and phenotypes.

Abbreviations: SOCS = Suppressor of Cytokine Signaling, CIS = Cytokine inducible
SH2 containing protein, SSI = STAT induced STAT inhibitor, JAB = JAK binding
protein, CNTF = ciliary neurotrophic factor, EPO = erythropoietin, G-CSF =
granulocyte colony stimulating factor, GM-CSF = granulocyte-macrophage colony
stimulating factor, GH = growth hormone, IFN = interferon, IGF-1 = insulin like growth
factor, LIF = leukemia inhibitory factor, LPS = lipopolysaccharide, OSM = oncostatin,
PKC = protein kinase C, TNF = tumor necrosis factor, TPO = thrombopoietin, TSLP =
thymic stromal lymphopoietin
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Chapter II
The Drosophila genome encodes three putative SOCS
homologues
INTRODUCTION
The eight mammalian SOCS genes can be readily identified by their distinct
modular arrangement of domains (Fig. 2-1). Specifically, each member of the family has
a central SH2 domain followed closely by a carboxy-terminal SOCS domain. The ~70
amino acid SH2 domain permits interactions with phosphotyrosine residues of activated
JAK/STAT components and the ~40 amino acid SOCS domain targets bound molecules
for proteosomal degradation. Additionally, SOCS-1 and SOCS-3 share a third functional
motif directly preceding the SH2 domain, termed the KIR (Kinase Inhibitory Region).
This 24 amino acid motif resembles a JAK activation loop and is believed to allow these
SOCS to act as a pseudosubstrate, inhibiting JAK catalytic activity (Narazaki et al., 1998;
Nicholson et al., 1999; Yasukawa et al., 1999). The amino termini of mammalian SOCS
proteins are divergent in both length and composition. However, SOCS proteins can be
divided into two classes based on the length. SOCS-1 to SOCS-3 as well as CIS all are
less than 300 amino acids in length, while the remaining SOCS (SOCS-4 to SOCS-7) are
all longer than 400 amino acids.
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RESULTS
BLAST analysis identified three putative SOCS genes in the fly genome
Using the modular domain architecture of mammalian SOCS as a guide, we
searched the Drosophila genome for putative SOCS homologues. Specifically, the
consensus SOCS sequence (Hilton et al., 1998) was used as a query in a tBLASTn search
of the Drosophila genome. Open reading frames that contained a SOCS domain were
further queried for an upstream SH2 domain. Three putative SOCS were identified using
this approach and were named Socs16D, Socs36E, and Socs44A based upon their
cytological position in the genome. All three Drosophila SOCS contain the expected
arrangement of domains, in that they each have a SH2 domain followed by a SOCS
domain located at the carboxy terminus of the locus. None of the Drosophila SOCS have
sequence in common with the KIR of SOCS-1 and SOCS-3. Like their mammalian
counterparts, their amino termini are divergent; however, all of them are at least 350
amino acids in length (Fig. 2-1).

Phylogenetic relationships between Drosophila and mammalian SOCS
A multiple sequence alignment based upon conceptual translations of the
Drosophila SOCS and their mammalian counterparts reveals that there is high degree of
similarity in the carboxy portions of SOCS proteins across taxa, however, the amino
termini remain divergent. Socs36E is the most similar to mammalian SOCS, sharing
71% similarity to murine SOCS-5 and 68% similarity to murine SOCS-4 over the last
180 amino acids comprising the SOCS, SH2, and the immediate 30 amino acids
preceding the SH2 domain. Socs16D is most similar to murine SOCS-6, sharing 44%
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similarity. Socs44A is least similar to mammalian SOCS, but it does share 43%
similarity to murine SOCS-6 (Fig 2-2). As expected, these similarities were found solely
in the SH2 and SOCS domains, and in the case of Socs36E, the similarity extended into
the 30 amino acid region preceding the SH2 domain. However, this sequence shared no
similarity to the analogous region defined as the KIR for SOCS-1 and SOCS-3.
From this alignment, we can infer a phylogenetic relationship between these
SOCS (Fig 2-2). It appears that there are three distinct clades of SOCS of which there
were at least two present at the time of divergence of mammals and dipterans. These two
clades include Socs36E which diverged into SOCS-4 and SOCS-5 and the tandem of
Socs16D and Socs44A which diverged into SOCS-6 and SOCS-7. The third clade,
which comprises CIS and SOCS-1 to SOCS-3, is not present in flies.

Cloning of Drosophila SOCS genes
Two distinct clones for Socs36E were recovered in an embryonic cDNA library
screen (Fig 2-3 and G. Rennebeck, unpublished). The first clone (designated 2.1.1)
contains the expected domain architecture, including complete SH2 and SOCS domains.
The second clone (designated 6.3.1) lacks the SOCS domain as well as most of the SH2
domain. Another lab observed two distinct transcripts in a Northern analysis
corresponding to Socs36E, one consistent with a full length clone (3.5kb), while the other
was 2.3kb, smaller than the 2.75kb abbreviated clone recovered in our screen (Callus and
Mathey-Prevot, 2002). Our full length clone indicates that the Socs36E locus is
comprised of four exons and three introns. The 5’ most intron is nearly 10kb in length
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and contains two clusters of four putative Stat92E binding sites (Fig. 2-3, Yan et al.,
1996b).
I PCR amplified an 1133bp fragment comprising the predicted start and stop
codons for Socs44A. Subsequently, we acquired a larval/pupal derived EST
corresponding to the Socs44A locus (LP02169). This EST was sequenced in its entirety
(Sanger et al., 1977) and deposited into Genbank (Accession AF435923, Fig 2-4).
Another EST isolated (GM29526) from ovaries is consistent with the larval/pupal clone.
Both ESTs are consistent with the predicted start and stop codons for this locus. The
larval/pupal EST contains a 74bp 5’ UTR,, 2 exons measuring 557 and 472 nucleotides,
and a 681bp 3’ UTR (Fig 2-3). This EST is predicted to encode a 342 amino acid
protein, approximately 38kD in size. Comparison of the EST sequence to genomic
sequence reveals that the locus has but a single 62bp intron. Analysis of all genomic
sequences 10kb upstream and downstream failed to detect the presence of any clusters of
putative Stat92E binding sites.
The Berkeley Drosophila Genome Project (BDGP) recovered 2 ESTs
corresponding to the third SOCS homologue, Socs16D: an embryonic EST and an EST
derived from Drosophila S2 cells (Fig. 2-3, FlyBase Consortium, 2003). The S2 cell
derived EST (SD11104) contains a larger amino terminus than the embryonic EST
(LD08944). Sequence analysis of the embryonic EST clone was inconsistent with the
sequence reported by the BDGP. Additionally, I was able to PCR amplify an 827bp
segment of the Socs16D genomic locus which could be used to isolate a full-length
cDNA from a library screen.
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DISCUSSION
Based on sequence similarity to a known modular architecture, we identified three
putative SOCS homologues in Drosophila. Each of these SOCS genes contains the
expected arrangement of the SH2 and SOCS domains at their carboxy terminus and an
amino terminus of variable length. While the amino termini of SOCS-1 and SOCS-3 are
functionally dispensable, this did not extend to the other SOCS family members
(Nicholson et al., 1999). Therefore, it is not surprising to find such disparity among
SOCS across taxa in this regard.
Phylogenetic analysis revealed that there are perhaps three distinct clades of
SOCS genes (Fig 2-2). The four most studied mammalian SOCS genes all belong to a
single clade that has no Drosophila homologues. This absence may be reflective of this
clade arising after the evolution of dipterans, or that this clade was lost in Drosophila.
Examination the closely related Drosophila pseudoobscura genome as well as the
recently completed Anopheles gambiae genome will be required to address this issue.
Or, perhaps this is reflective of SOCS functions that are unique to chordates. Socs36E is
most similar to SOCS-4 and SOCS-5 while Socs44A is most similar to SOCS-6,
accounting for the other two observed SOCS clades. This would suggest that the
functions of Socs36E and Socs44A may be representative of the lesser studied
mammalian SOCS genes. The presence of the sole C. elegans SOCS homologue in the
same clade as Socs44A and Socs16D could suggest that these arose from the “original”
SOCS gene and may be representative of a more generalized SOCS.
It is sometimes possible to infer evolutionary decent by analysis of intron/exon
structures; however, the Drosophila SOCS genes do not share similar intron/exon
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structures. Socs44A is perhaps the simplest, containing 2 exons and a single, small 62bp
intron. There is evidence that both Socs36E and Socs16D have multiple splice forms. In
the case of Socs36E, this is supported by isolation of embryonic cDNAs and Northern
analysis (Callus and Mathey-Prevot, 2002). ESTs from the BDGP indicate that Socs16D
may have two splice variants, the only difference between them being the size of the
amino terminus of the resulting protein. Both Socs16D and Socs36E are spliced within
the SH2 domain; however, the location of this splice site is not conserved. Both splice
junctions occur in a less conserved region of the SH2 domain near the carboxy end.
Altogether, these observations are consistent with the divergence of three clades of SOCS
proteins.
The general mechanism of SOCS regulation of signal transduction is based on a
simple negative feedback loop. SOCS genes respond to JAK/STAT pathway activity and
in turn act to downregulate the cascade. The possession of both an SH2 and SOCS
domain indicates that Drosophila SOCS genes may at least be capable of downregulating
the cascade in flies. Furthermore, the presence of two clusters of Stat92E binding sites in
the 5’ intron of Socs36E suggests that it may also be responsive to pathway activity,
consistent with the negative feedback loop model. In contrast, the Socs44A and Socs16D
loci and surrounding genomic regions do not contain a similar cluster of Stat92E binding
sites, which suggests that they may not be responsive to the JAK/STAT cascade.
Nevertheless, these findings provided sufficient motivation for the study of these genes as
potential regulators of Drosophila JAK/STAT signaling.
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Figure 2-1. Domain architecture of SOCS. Eight mammalian SOCS have been
identified and designated CIS and SOCS-1 to SOCS-7. Based on the modular domain
architecture shared by these proteins, we identified three putative Drosophila SOCS
homologues, designated Socs16D, Socs36E, and Socs44A based upon their cytological
position in the fly genome. The proteins are depicted to scale and length of each SOCS is
indicated to the right and the coloring scheme is defined below the figure.

21

Figure 2-2. Protein sequence comparison of Drosophila and mouse SOCS. (A) The
predicted protein sequences of fly and selected mouse SOCS genes are aligned and
shaded to indicate similarities and identities. Fly Socs36E is most similar to mouse
SOCS-5, while the remaining fly homologues, Socs16D and Socs44A, are more distantly
related to mouse SOCS-6 and SOCS-7. (B) Phylogenetic analysis of SOCS genes
indicates that there are perhaps three clades of SOCS. Drosophila Socs36E is located in
the same clade as mouse SOCS-4 and SOCS-5, while Drosophila Socs16D and Socs44A
share the same clade as mouse SOCS-6 and SOCS-7. The most studied mammalian
SOCS (CIS and SOCS-1 to SOCS-3) occupy the third clade.

22

Figure 2-3. Schematics of Drosophila SOCS cDNAs. Transcribed regions are
indicated by boxes. The SH2 domain is blue, the SOCS domain is red, while light gray
indicates untranslated regions and dark gray indicates undefined regions of the
polypeptide. Two potential Stat92E binding sites are indicated by closed circles. The
EST or clone reference is indicated to the right. Further information about these clones
can be found in the text.
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Figure 2-4. Nucleotide sequence of Socs44A. The sequence of the Socs44A EST
LP02169 is shown. The conceptual translation of the Socs44A protein is indicated in one
letter amino acid code above the corresponding nucleotide sequence. The SH2 domain is
shaded blue and the SOCS domain is shaded yellow. Primers used in sequencing are
indicated in red. The closed arrowhead indicates the location of the intron (see Fig 2-3).
The open arrowhead indicates the location of the PiggyBac P-element insertion (see
chapter five).
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Chapter III
The role of Drosophila SOCS in the JAK/STAT cascade
INTRODUCTION
Regulation of signal transduction can serve two purposes. First, it can act to
attenuate the amplitude or duration of a signal in order to elicit the appropriate response.
Second, the signaling pathway must have a means to reset itself so that the cell can
respond to future signals. These regulatory phenomena are required throughout
development and homeostasis. A common mechanism for such regulation is the negative
feedback loop, which allows a signaling cascade to regulate itself based upon activation
of the pathway.
The four well-studied mammalian SOCS genes (CIS, SOCS-1 to SOCS-3) have
been shown to operate in a classical negative feedback loop to regulate the JAK/STAT
pathway. Cytokines and growth factors induce pathway activation resulting in the
modulation of target gene transcription, including SOCS. The expression of CIS, as well
as SOCS-1 to SOCS-3 can be induced by a variety of interleukins, interferons, growth
hormones, and colony stimulating factors (reviewed in Fujimoto and Naka, 2003).
However, the pattern of SOCS induction seems to be tissue or cell-line specific. For
example, IFN-γ induces SOCS-1 and SOCS-3 expression in NIH-3T3 cells, but only
SOCS-1 in M1 cells (Sakamoto et al., 1998). Likewise, growth hormone can induce CIS,
SOCS-2, and SOCS-3 expression in the mouse liver, but only CIS and SOCS-2 are
induced in the mammary gland (Davey et al., 1999). The general observation is that
multiple SOCS are induced by a single cytokine in a tissue specific manner.
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After pathway activation and induction of gene expression, SOCS can act to
downregulate JAK/STAT signaling by a variety of mechanisms described previously.
CIS, as well as SOCS-1 to SOCS-3 have been shown to inhibit signaling by an array of
cytokines. However, there is no pattern to the relationship between the SOCS proteins
and the cytokines they inhibit. Considering only the interleukins, CIS is induced by IL-2,
IL-3, IL-6, and IL-9; however, it can only inhibit IL-2 and IL-3 signaling (reviewed in
Fujimoto and Naka, 2003) Conversely, SOCS-5 is induced by IL-6 but can negatively
regulate IL-4 in addition to IL-6 signaling (Heinrich et al., 2003; Nicholson et al., 1999).
Clearly the activity of SOCS is more complex than a “simple” negative feedback
loop. The observations mentioned above indicate that there is considerable crosstalk
among cytokines via SOCS. With numerous ligands and receptors for the mammalian
JAK/STAT pathway, dissection of SOCS function is an arduous task at best, lending
credence to the study of SOCS in the relatively simplistic Drosophila JAK/STAT system.
This chapter examines the roles of the Drosophila Socs36E and Socs44A in the
JAK/STAT pathway. Specifically, we show that Socs36E expression is dependent on
JAK activity and it is responsive to JAK pathway activation. These observations are
consistent with a recently published report (Karsten et al., 2002). On the other hand,
Socs44A failed to respond to JAK/STAT activation. Likewise, a reduction in pathway
activity had no effect on Socs44A expression. Others showed that Socs36E could
negatively regulate the JAK/STAT cascade during wing development (Callus and
Mathey-Prevot, 2002). We extend this by illustrating that Socs36E can also negatively
regulate the pathway during oogenesis. Socs44A appears to have tissue specificity in its
regulation of the pathway. While it is able to regulate JAK/STAT signal transduction in
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wing development, it does not regulate the pathway during follicular development in
oogenesis.

RESULTS
Expression patterns of Drosophila SOCS
If Socs36E and Socs44A were responsive to JAK/STAT signaling, we would
expect them to have similar patterns of expression to known components of the pathway.
The role of the JAK/STAT pathway in proper segmentation of the embryo has been well
established (Binari and Perrimon, 1994; Harrison et al., 1998; Hou et al., 1996; Perrimon
and Mahowald, 1986; Yan et al., 1996b). It has been shown that the cascade coordinates
expression of several of the pair-rule class of genes, including even-skipped, fushi turazu,
and runt (Binari and Perrimon, 1994; Small et al., 1996). The ligand, unpaired, is
expressed in a distinctive, dynamic pattern during embryogenesis (Harrison et al., 1998).
Early on, transcripts are detected broadly in the embryo and later refined to seven and
then fourteen stripes during gastrulation, resembling the classical pair-rule pattern of
expression. At germ band retraction, expression is restricted to the tracheal pits, hindgut,
and other structures. Whole mount in situ hybridization to mRNA in embryos (work
done by G. Rennebeck) revealed that Socs36E expressed in a strikingly similar pattern
throughout embryogenesis (Fig. 3-1). The principle difference is that the domain of
Socs36E expression appeared to be broader than that of unpaired. In embryogenesis,
expression of Socs44A is not similar to unpaired (Fig. 3-1). Its expression can be seen
only in the dorsal trunk and lateral braches of the tracheal system of late stage embryos.
No expression can be detected in earlier stages, to include the tracheal pits at germ band
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retraction. It must be noted that tracheal staining is a common artifact in mRNA in situ
hybridization. Therefore, it is possible that the observed expression pattern is not
legitimate. However, we did not detect tracheal staining with sense mRNA control
probes. Furthermore, the tracheal staining was consistent with both DNA and RNA
probes generated from variety of polymerases. We also examined animals homozygous
for the Df(2R)CA53 deficiency which includes the Socs44A locus. These embryos died
before the onset of tracheal morphogenesis.
Similar results were seen when expression of these SOCS genes was observed
during oogenesis (Fig. 3-1). In the developing egg chamber, unpaired is expressed
specifically in the two polar follicle cells found at each end of the egg chamber. Socs36E
is also expressed at the poles (work done by G. Rennebeck), but again, its domain of
expression is much broader than that of unpaired. In contrast, Socs44A was not
expressed in the somatic epithelium; however, transcripts were detected in germline,
accumulating in the oocyte by stage 8.

Socs36E but not Socs44A is responsive to the JAK/STAT signal
To more directly assess the role of JAK/STAT signaling on the expression of
Socs36E and Socs44A, mRNA in situ hybridizations were performed on embryos that
lacked JAK/STAT pathway activity. We presumed that a decrease in cascade activation
would result in a decrease in SOCS expression. Hopscotch, the Drosophila JAK, is an
essential gene that has both maternal and zygotic functions and is required for early
embryogenesis. Therefore, we utilized the dominant female sterile technique (DFS) to
generate females that fail to produce hop in the germline (Chou and Perrimon, 1992).
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Mating these females to wild-type males produces two populations of embryos. Because
hopscotch is X-linked, the resulting male embryos are null for hop, while females are
paternally rescued because they receive one zygotic copy of hop from their fathers. It has
been documented that this technique produces embryos with the expected segmentation
defects associated with hop loss of function (Binari and Perrimon, 1994). In situ
hybridization of Socs36E mRNA in these hop germline clone derived animals (work done
by G. Rennebeck) revealed a marked reduction in Socs36E expression. Half of the
embryos (presumably the males) showed no staining above basal levels, with the
exception of a persistent mesodermal expression (Fig. 3-2). In situ hybridization of
Socs44A mRNA to hop germline clone derived embryos did not result in reduction in the
tracheal staining. Interestingly, these animals had vastly reduced tracheal tissue as
marked by the trachealess-LacZ enhancer trap (Fig. 3-2). The little tracheal tissue that
was present was disorganized and did not resemble normal tracheal morphology. The
paternally rescued animals had near wild-type trachea with only minor migration defects
present. This phenotype is consistent with previous data illustrating the role of the JAK
receptor, domeless, in tracheal morphogenesis (Brown et al., 2001). The failure to reduce
the tracheal staining in hop germline clone derived animals suggests that Socs44A
expression is not affected by loss of JAK pathway activity. These data indicate that while
Socs36E expression is dependent on JAK/STAT activity, it is not the case for Socs44A.
The above assays do not address whether Drosophila SOCS are responsive to
pathway activation. Recent work has shown that overexpression of unpaired or other
JAK/STAT components could induce the expression of Socs36E (Karsten et al., 2002 and
G. Rennebeck, unpublished). However, misexpression of upd using a paired-GAL4
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driver failed to induce embryonic Socs44A expression (data not shown). Taken together,
these data indicate that Socs44A is not dependent upon or responsive to the JAK/STAT
pathway during embryogenesis.

Socs44A regulation of JAK/STAT signaling in wing development
The JAK/STAT pathway has been implicated in the development of the wing vein
pattern. The hypomorphic statHiJak mutant exhibits ectopic wing vein material in the
posterior compartment of the wing at the posterior crossvein (Yan et al., 1996a). A
strikingly similar phenotype is seen in certain heteroallelic combinations of hop mutants
(Fig. 3-4). If SOCS negatively regulate JAK/STAT signaling in flies, we would expect
misexpression in the posterior to cause a similar phenotype. Indeed, misexpression of
two copies of a Socs36E transgene using the engrailed-GAL4 driver produced a similar
phenotype (Callus and Mathey-Prevot, 2002 and G. Rennebeck, unpublished).
It is possible that Socs44A could negatively regulate the JAK/STAT pathway
even though it is unable to respond to its signal because these events are uncoupled. To
address this issue, Socs44A was subcloned from the full length LP02169 EST into the
pUAST vector and the resulting construct was used in the standard transformation
technique to generate transgenic animals (Spradling, 1986). These animals express
Socs44A under the control of the GAL4/UAS binary expression system (Brand and
Perrimon, 1993). GAL4, a yeast transcription factor, is not expressed in Drosophila, nor
does it induce expression of endogenous genes. However, GAL4 recognizes the
upstream activating sequence (UAS) that precedes the subcloned Socs44A transgene.
The UAS-Socs44A transgenic flies were then mated to an array of established lines that
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express GAL4 under the control of a variety of enhancers providing both temporal and
spatial control of misexpression (FlyBase Consortium, 2003; Harrison et al., 1995;
Tracey et al., 2000).
Socs44A was misexpressed in a variety of tissues (Table 3-1). In most cases,
misexpression of Socs44A was either lethal or had no discernable effect. However,
misexpression of Socs44A in the wing yielded several phenotypes (Fig. 3-3). In all cases,
misexpression in the wing caused either formation of ectopic wing vein material and/or
alterations in the guidance of the lateral or cross veins. Patched encodes a receptor
involved in hedgehog signaling and is expressed specifically along the anterior/posterior
boundary in the wing imaginal disc (Capdevila et al., 1994). Patched-GAL driven
misexpression of Socs44A along this boundary, which is located between the third and
fourth lateral veins (L3 and L4), caused both of these veins to pinch together at the
anterior crossvein. Misexpression using the GAL-T6 driver also caused this pinching
phenomenon and also resulted in ectopic wing vein material extruding from the anterior
side of L4. GAL-T113 misexpression resulted in the formation of one or more ectopic
crossveins between L2 and L3. Misexpression of Socs44A using the engrailed-GAL4
driver also resulted ectopic wing vein formation around the posterior crossvein (Fig. 3-4).
This ectopic material can be seen as a thickening of the PCV at the distal ends where it
intersects L4 and L5. Additional ectopic material is also seen beneath L5 and at the most
distal portions of L4 and L5. Finally, these wings also exhibit an exaggerated arching of
L3.
While misexpression of Socs44A results in phenotypes similar to and consistent
with JAK/STAT mutants, it does not directly address the capacity of Socs44A to
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downregulate the pathway. The engrailed-GAL4 driven Socs44A wing phenotype is
fully penetrant. The addition of a single copy of the hopc111 null allele enhances this
phenotype (Fig. 3-4), which would be expected of a negative regulator of JAK/STAT
signaling. Misexpression of hop using the engrailed-GAL driver results in complete loss
of L5 and the most of PCV as well as ectopic wing venation at the anterior crossvein
(ACV). Concurrent misexpression of Socs44A in this background rescues the wing vein
defects, restoring the PCV and L5 (Fig. 3-4). The resulting wing has ectopic wing vein
material at the distal part of L5 and occasionally along L3 and arching of L3 is also
present in these wings, phenotypes attributed to misexpression of Socs44A alone. Taken
together, these data suggest that Socs44A is capable of downregulating the JAK/STAT
pathway during development of the wing.
Socs44A appears capable of downregulating the JAK/STAT pathway during wing
development, but is that reflective of the endogenous activity in vivo? The PCV wing
vein spur associated with a specific heteroallelic combination of hop is 98% penetrant
(n=89). Furthermore, these flies show a reduction in viability. It would be expected that
misexpression of Socs44A would enhance these phenotypes. Misexpression of Socs44A
in three different transheterozygous combinations of hop always resulted in lethality
(Table 3-2). Exacerbation of the reduced viability caused by the hop mutations is
consistent with a role in downregulating the JAK/STAT cascade. These data indicate that
ectopic expression of Socs44A has the capacity to downregulate endogenous hop in the
developing wing.
In a reciprocal assay, we would expect that a reduction in Socs44A would rescue
the hop transheterozygous wing spur phenotype. Currently, a loss of function allele of
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Socs44A has not been isolated. In lieu of this, there are several deficiencies that remove
the Socs44A locus. CA53 and NCX10 are deficiencies that lack Socs44A by virtue of
their failure to complement lethal P-element insertions that flank either side of the locus.
A single copy of either of these deficiencies when placed in a hopM38/msv background
partially rescued the PCV wing spur phenotype, reducing the penetrance by as much as
52% (Fig. 3-5). These observations suggest that endogenous Socs44A downregulates
hop in wing development. Unexpectedly, these animals often had misguided PCVs that
failed to connect to L4 and occasional perturbations of the ACV.

Socs36E but not Socs44A regulates JAK/STAT signaling in oogenesis
As mentioned previously, mammalian SOCS responsiveness and subsequent
pathway regulation is context specific (reviewed in Johnston and O'Shea, 2003). We
utilized the Drosophila ovary to test if there is tissue specificity to Socs44A regulation of
the cascade. Recent work has established that the JAK/STAT pathway is responsible for
patterning the somatic follicle cells of the vitellarium (Beccari et al., 2002; McGregor et
al., 2002; Silver and Montell, 2001; Xi et al., 2003). Specifically, JAK activity is
essential for identification of the posterior terminal follicle cells (Xi et al., 2003). These
cells are molecularly defined by the expression of the ETS domain transcription factor,
pointed (Gonzalez-Reyes and St Johnston, 1998; Morimoto et al., 1996; Roth et al.,
1995). Expression of the pointed protein is detected as a gradient emanating from the
posterior pole of developing egg chambers. Clones of cells in the posterior that lack hop
activity fail to express the reporter, pnt-LacZ (Xi et al., 2003) establishing this as an assay
for JAK pathway activity.
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Clones of cells misexpressing either Socs36E or Socs44A in the posterior of
developing egg chambers were generated using the FLP-OUT cassette technique
(Neufeld et al., 1998; Struhl and Basler, 1993). Clones of cells misexpressing Socs36E at
high levels in the posterior cells of the developing egg chamber exhibited a loss of the
pnt-LacZ marker (Work done by R. Xi, Fig. 3-6). However, when Socs44A was
misexpressed in a similar fashion, there was no reduction of pnt-LacZ expression (Fig. 36). These data suggest a functional role for Socs36E but not Socs44A in the regulation of
JAK signaling in oogenesis. These data also suggest that context specificity of SOCS
regulation of the JAK pathway is conserved across taxa.

DISCUSSION
In this chapter, the role of Socs44A in JAK/STAT signaling was examined. It has
been shown that the four well-studied mammalian SOCS (CIS and SOCS-1 to SOCS-3)
respond to and downregulate the JAK/STAT cascade in a classical negative feedback
loop. However, it should be noted that SOCS-4, SOCS-6, and SOCS-7 have not been
shown to be induced by any cytokine or growth factor. Furthermore, SOCS-4 and SOCS7 have not been shown to inhibit JAK/STAT signaling in vitro or in vivo (reviewed in
Fujimoto and Naka, 2003).
Socs36E appears to be able to respond to and downregulate the JAK/STAT
pathway in flies, indicating that this mechanism of JAK/STAT regulation is conserved.
First, Socs36E is expressed in a dynamic pattern strikingly similar to the ligand,
unpaired. We observed that in both embryos and ovaries, the domain of Socs36E
expression exceeded that of unpaired. This observation is consistent with the model that
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Socs36E is responsive to JAK/STAT signaling. Unpaired is a secreted molecule which
could induce pathway activation in neighboring cells, leading to Socs36E expression in
those cells, creating a broader domain of Socs36E expression. Although diffusion of Upd
has not been directly observed, Upd expressed in follicle cells of the ovary leads to JAK
activation in neighboring cells (Xi et al., 2003) which would presumably lead to
expression of Socs36E in those cells. Second, ours and other labs have shown that
Socs36E expression can be induced by ectopic activation of the JAK/STAT pathway
(Karsten et al., 2002 and G. Rennebeck, unpublished). Finally, reduction of cascade
activity has a direct effect on Socs36E expression (work done by G. Rennebeck, Fig. 32). Interestingly though, in hop null animals, mesodermal expression of Socs36E
persisted. This suggests that there may be alternative pathways that activate Socs36E
transcription in those tissues.
Socs44A mRNA expression was detected in both ovarian and embryonic tissues in
patterns inconsistent with JAK pathway activation. During oogenesis, an accumulation
of transcripts was detected in the germline during the period when maternal RNAs are
loaded into the oocyte. Further expression was not detected until late stages of
embryogenesis, when it was restricted to the trachea. However, the expression of
unpaired in the tracheal pits (Fig. 3-1) coupled with studies implicating a role for
JAK/STAT signaling in tracheal morphogenesis (Brown et al., 2001) support our
findings. Furthermore, the existence of both embryonic and ovarian ESTs supports the
observed temporal expression patterns.
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Through misexpression, it was shown that Socs44A has the capacity to
downregulate ectopic activated Hop. Additionally, the loss-of-function mutation hopc111
enhances the Socs44A misexpression phenotype. Consistent with these data,
misexpression of Socs44A exacerbates the reduced viability associated with
transheterozygous hop mutants. Finally, deficiencies for Socs44A rescue hop
heteroallelic phenotypes. Taken together, these data strongly suggest that endogenous
Socs44A downregulates JAK pathway activity in vivo. In contrast, misexpression of
Socs44A had no effect on expression of a marker for JAK pathway activity during
oogenesis. However, it must be noted that both the EGFR/MAPK and JAK/STAT
pathways work synergistically to pattern the posterior terminal follicle cells in oogenesis
(Gonzalez-Reyes and St Johnston, 1998; Roth et al., 1995; Xi et al., 2003). Roles of
Socs44A in EGFR/MAPK signaling will be examined in chapter four; this issue will be
revisited there. Nonetheless, our observations indicate that there may be context
specificity to SOCS activity in Drosophila, a phenomenon that has been observed in the
study of mammalian SOCS.
When we attempted to rescue the wing spur phenotype associated with certain
heteroallelic combinations of hop by introducing a single copy of Socs44A-containing
deficiency, we observed unexpected wing phenotypes. While the penetrance of the hop
heteroallelic phenotype was reduced, we observed wings with misguided PCVs and
occasional perturbations of the ACV. Both of these defects appeared to be the result of
failure of the crossvein to migrate properly. The development and placement of
crossveins is believed to be the result of signaling from the Jun Kinase, BMP,
EGFR/MAPK, and Notch pathways (reviewed in Marcus, 2001). Although the role of
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JAK/STAT signaling in wing venation has not been determined, hop (Fig. 3-5) and
Stat92E (Yan et al., 1996a) mutant phenotypes suggest that this pathway is somehow
involved in this process.
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Figure 3-1. Socs36E but not Socs44A is expressed similarly to upd in both
embryogenesis and oogenesis. The embryonic expression patterns of upd (first column)
are remarkably similar to the patterns of expression of Socs36E (second column), while
Socs44A expression patterns (third column) are distinct. At each stage during embryonic
development, the dynamic pattern of upd expression (A, D, F, and H) is nearly matched
by Socs36E expression (B, E, G, and I). Socs44A expression is not detected until later
stages, where it is restricted to the trachea (C and J). In the ovary, upd is expressed
specifically in the polar follicle cells at each end of the chamber (K). Socs36E expression
encompasses the entire anterior and posterior polar caps of post-germarium stage
chambers. See text for more details. Upd and Socs36E in situs done by G. Rennebeck.
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Figure 3-2. Socs36E but not Socs44A expression is dependent on JAK activity. As
compared with wild-type at various embryonic stages (A, B, and C), germline clone
derived embryos from hopc111 mothers display dramatically reduced or eliminated
expression of Socs36E (D, E, and F). Only a stripe of mesodermal staining in germ band
extended mutant embryos (F) remains at near normal intensity. Expression of Socs44A
persists in hopc111 germline clone derived embryos (G and H). However, the tracheal
morphology is drastically reduced in these animals (G) and somewhat reduced in animals
that are paternally rescued (H), evidenced by the trachealess-LacZ enhancer trap (I).
Panels A - F are the work of G. Rennebeck.
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Figure 3-3. Wing misexpression phenotypes generated with the Socs44A transgene.
Anterior is up and posterior is down for all wing figures. A Socs44A transgene was
misexpressed using the GAL4/UAS binary system (Brand and Perrimon, 1993) altering
the wing vein pattern seen in wild-type wings (A). When misexpressed along the A/P
axis with a patched GAL4 driver, the L3 and L4 pinched together at the ACV (B).
Misexpression with other wing drivers resulted in ectopic wing vein formation (C) or
extra crossveins (D).

40

Figure 3-4. Socs44A is capable of downregulating the JAK/STAT cascade in the
wing. Engrailed-GAL4 misexpression of Socs44A in the posterior half of the wing
results in ectopic wing venation (A) that is enhanced by the addition of a single copy of
the hopc111 null allele (B). Engrailed-GAL4 misexpression of hopscotch results in a loss
of L5 and most of the PCV and ectopic wing venation near the ACV. This phenotype is
rescued by the concurrent misexpression of Socs44A (D). The PCV and L5 are restored
and the amount of ectopic wing vein is reduced.
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Figure 3-5. Endogenous Socs44A regulates JAK pathway activity. The
hopmsv/hopM38 transheterozygote has a wing spur phenotype (A) that is 98% penetrant
(n=89). A single copy of a deficiency (Df(2R)CA53 or Df(2R)NCX10) that includes the
Socs44A locus can rescue this phenotype resulting in reduced (B, arrowhead) or
misguided (B, arrow) crossveins. Furthermore, the penetrance of the spur phenotype is
dramatically reduced (C). This phenomenon was not seen with a local deficiency that
does not include Socs44A (C, Df(2R)Drlrv18).
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Figure 3-6. Socs36E but not Socs44A regulates JAK activity during oogenesis. In
wild-type ovaries (first column), pnt-lacZ (red) is expressed in a gradient in the posterior
terminal cells. Cells that lack hop activity (marked by a lack of green, see outline), also
fail to express pnt-lacZ (second column). Similarly, UAS-Socs36E expressed in clones
(marked by presence of green, see outline), have reduced or missing pnt-LacZ expression
(third column, see insets). Conversely, UAS-Socs44A expressed in clones (marked by
presence of green, see outline), had no effect on pnt-LacZ expression (third column).
DAPI nuclear staining is shown in blue. Panels A – H are the work of R. Xi.
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Table 3-1. Socs44A misexpression phenotypes.

The UAS-Socs44A transgene was crossed to an array of GAL4 drivers (FlyBase
Consortium, 2003; Harrison et al., 1995). ACV, anterior crossvein; cut, cuticle; discs,
imaginal discs; FB, fat bodies; LG, lymph gland; Malp, Malpighian tubules; MB,
mushroom body; OL, optic lobes; PR, pair-rule pattern; SG, salivary glands; Tr, trachea;
VNC, ventral nerve cord. Asterisks indicate phenotypes scored from crosses performed
at 290C all other crosses performed at 250C.
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Table 3-2. Misexpression of Socs44A exacerbates the reduced viability of hop
heteroallelic mutants.

Misexpression of Socs44A in a range of hop heteroallelic mutants resulted in lethality.
For each mutant combination, n represents the total number of progeny scored in the
cross. The number of progeny of each genotype is indicated. E represents the expected
number of progeny of that genotype if Socs44A misexpression were to have no effect on
viability, where E = b/a x c.
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Chapter IV
Socs44A is capable of interacting with the EGFR/MAPK
pathway
INTRODUCTION
The number of developmental and homeostatic programs far surpasses the
number of signal transduction pathways that control them. One method of compensation
for this deficit is the crosstalk among signaling cascades. Crosstalk permits a higher
order of complexity resulting in a greater number of possible responses without
increasing the number of cascades that generate them. Combinatorial control of gene
expression through crosstalk may serve to attenuate transcription levels and possibly
contribute to the robustness to changes in gene dosage that are inherently compensated
for by signaling cascades (Eldar et al., 2002).
There is considerable interplay between the JAK/STAT and several other
cascades (Heinrich et al., 2003; Rane and Reddy, 2000; Shuai, 2000). This is not
surprising because certain species lack some of the components required for activation
and propagation of the JAK/STAT signal. For example, the slime mold Dictyostelium
possesses three STAT molecules but lacks any other component. The nematode, C.
elegans, also possesses a STAT molecule, as well as a predicted protein with high
similarity to SOCS, but also lacks a JAK or other components (see reviews by Dearolf,
1999; Rawlings et al., 2004). These observations imply that the STATs can be activated
by some other mechanism than by JAK phosphorylation. In fact, it has been shown that
STAT and SMAD (a TGF-β pathway molecule) can interface through p300 (Iwamoto et
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al., 2002; Moustakas, 2002). The phosphotyrosine docking sites on the JAK/STAT
receptor are inviting targets for interaction with other signal cascades as well. For
example, p85 interacts with the phosphorylated receptor. This molecule also interacts
with IRS (insulin receptor substrate) bridging JAK/STAT with the phosphoinositide 3kinase (PI3K) pathway (Foster et al., 2003).
Of particular interest is the EGFR/MAPK pathway, which has a bidirectional
interface with JAK/STAT on several levels (reviewed in Rawlings et al., 2004). The
protein tyrosine phosphatase SHP-2 (SH2 containing protein) interacts with the
JAK/STAT receptor gp130 as well as GRB2, an adaptor in the EGFR/MAPK cascade
(Qu, 2002). Also, it has been shown that JAK can activate MAPK through the Pyk2
intermediary (Takaoka et al., 1999). Several MAPKs can contribute to the
transcriptional ability of STATs via serine phosphorylation, independent of JAK
activation (David et al., 1996; Decker and Kovarik, 2000; Leaman et al., 1996). A recent
report directly links murine SOCS-3 to EGFR signaling. Specifically, SOCS-3 binds to
and degrades p120 RasGAP, the small GTPase responsible for inactivating Ras. The
result of this interaction is an upregulation of the EGFR/MAPK pathway (Cacalano et al.,
2001).
The interplay between JAK/STAT and EGFR/MAPK is also reflected in the
Drosophila model. In the follicular epithelium of the Drosophila ovary, JAK/STAT
pathway pre-patterns the termini and is required for EGFR competence in the posterior of
developing egg chambers (McGregor et al., 2002; Xi et al., 2003). Likewise, the MAPK
pathway is required for JAK driven differentiation of hematopoietic cells because a direct
interaction between hopscotch and D-Raf is required for the blood cell alterations caused
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by the hypermorphic hopTum-l and hopT42 alleles (Luo et al., 2002). Furthermore, Socs36E
has been reported to weakly suppress EGFR signaling in the wings (Callus and MatheyPrevot, 2002).
In this chapter, potential interactions between Socs44A and other signaling
cascades is explored. Strong evidence of a genetic interaction between Socs44A and the
EGFR/MAPK (Epidermal growth factor receptor/Mitogen-activated protein kinase)
pathway is presented. Specifically, Socs44A acts to upregulate the EGFR/MAPK
cascade, analogous to what was reported for mouse SOCS-3.

RESULTS
Interactions between Socs44A and other signaling cascades
As described previously, misexpression of Socs44A using the engrailed-GAL4
driver resulted in a fully penetrant phenotype marked by the presence of ectopic wing
vein material in the posterior compartment of the wing. To test possible dominant
interactions between Socs44A and other signaling pathways, flies were generated that
were heterozygous for mutations or carried GAL4/UAS compatible transgenes in an
engrailed-GAL4; UAS-Socs44A genetic background to determine if they had any effect
on the Socs44A misexpression phenotype. Members of the TGF-β, dpp
(decapentaplegic), and hedgehog pathways were tested (Table 4-1), none of which
showed any detectable modulation of the Socs44A misexpression phenotype. An
interaction between Socs44A and the EGFR/MAPK pathway was detected and will be
described in the next section.
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Socs44A interacts with the EGFR/MAPK pathway
Engrailed-GAL4 driven misexpression phenotypes of Socs44A were suppressed
in the background of heterozygous mutations for EGFR/MAPK components, including:
Ras85D, Son of sevenless (Sos), and Egfr (Table 4-1 and Fig. 4-1). Consistent with these
observations, reduction in the dosage of argos enhanced the Socs44A misexpression
phenotype. Argos is an extracellular ligand that possesses an EGF motif and acts as an
inhibitor of EGFR/MAPK signaling in the developing wing and other tissues (Sawamoto
et al., 1996; Sawamoto et al., 1994; Schweitzer et al., 1995). Concurrent misexpression
of Socs44A and argos also showed a phenotypic interaction consistent with the previous
data. Misexpression of two copies of an argos transgene under the engrailed-GAL4
driver resulted in wings lacking the 4th lateral vein (L4) as well as both cross-veins (Fig.
4-2). Concurrent misexpression of a single copy of the Socs44A transgene in this
background was able to rescue this phenotype, restoring the posterior crossvein and both
the most proximal and distal portions of L4. The resulting wing phenotype mimicked
that seen when only a single copy of argos was used in the misexpression assay or what
is seen in heteroallelic Egfr mutants. Finally, concurrent misexpression of a single copy
of the argos and Socs44A transgenes produced a nearly wild-type wing. These data
indicate that Socs44A expression is able to suppress argos misexpression phenotypes in a
dose-dependent manner. It should be noted that concurrent misexpression of the gene
encoding GFP did not have similar effects in these assays (Fig. 4-5), indicating that the
phenotypes produced were not merely a consequence of titrating GAL4.
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To address whether endogenous Socs44A activity had a similar effect on EGFR
pathway activity, we assayed the effects of a Socs44A deficiency in the argos
misexpression background. Engrailed-GAL4 misexpression of argos produces a range of
phenotypic classes in which parts or all of L4 and/or the PCV are missing (Fig. 4-3).
Addition of a single copy of a Socs44A deficiency shifted the distribution of phenotypes
to the more severe classes compared to a deficiency that does not include the Socs44A
locus (Fig. 4-4). Taken with the previous data, these observations suggest that Socs44A
does indeed upregulate EGFR signaling in the Drosophila wing.
Not all proteins that interact with various MAPK pathways showed interactions
with Socs44A. For example, sevenless, the receptor used in eye development (Hafen et
al., 1994) had no effect on the Socs44A misexpression phenotype. Sprouty is an
intracellular inhibitor of the EGFR/MAPK pathway that possesses a mutant phenotype
similar to the engrailed-GAL4 driven misexpression phenotype of Socs44A (Casci et al.,
1999). In my hands, sprouty heterozygotes exhibited a PCV wing spur nearly identical to
hopM38/msv transheterozygotes. Addition of a deficiency that includes the Socs44A locus
had no effect on the penetrance of this phenotype. Veinlet is an allele of rhomboid, a
transmembrane protein that interacts with EGFR and promotes signaling during wing
development. Homozygous veinlet mutants exhibit wings that lack the distal portions of
all of the lateral veins (Guichard et al., 1999; Sturtevant et al., 1993). Removal of one
copy of Socs44A via a deficiency had no effect on this phenotype. These observations do
not contradict my previous findings because these assays tested for dominant interactions.
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DISCUSSION
Crosstalk is a common theme amongst signal transduction cascades. This
phenomenon is likely to serve multiple purposes. Among them are to allow a cell to
integrate multiple signals into a single response, or to contribute to the compensation for
changes in gene dosage required to maintain the fidelity of developmental and
homoeostatic processes dependent on signal transduction mechanisms.
While others have shown that Socs36E genetically interacts with and
downregulates the EGFR pathway (Callus and Mathey-Prevot, 2002), it is illustrated here
that Socs44A acts in the opposite manner. Socs44A is able to rescue misexpression of
the EGFR negative regulator argos in a dose-dependent manner. Furthermore, mutations
in EGFR pathway components rescue Socs44A misexpression phenotypes. Finally, a
loss of endogenous Socs44A activity enhanced the argos misexpression phenotype.
Taken together, these data indicate that Socs44A is upregulating the EGFR pathway.
This finding is consistent with a recent report describing an interaction between SOCS-3
and the p120 RasGAP (Cacalano et al., 2001). In this model, SOCS-3 degrades p120
RasGAP, the GTPase-activating protein responsible for inactivating Ras, resulting in an
upregulation of the EGFR/MAPK pathway. It is possible that Socs44A is acting in an
analogous manner; biochemical analyses are required to address this hypothesis.
Interactions were not detected between Socs44A and several known
EGFR/MAPK pathway proteins including: sevenless, sprouty, and veinlet. In addition,
interactions with other cascades were also not observed. Members of the Notch, Dpp,
Hedgehog, and TGF-β pathways were tested, none of which showed an interaction with
Socs44A in misexpression assays. This does not rule out interactions between Socs44A
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and EGFR/MAPK or those other pathways. The assay may not have been sensitive
enough or the location of misexpression may have been inappropriate to observe
interactions. In light of the fact that Socs44A regulation of JAK signaling seems to be
context specific, it is possible the interactions between Socs44A and other cascades may
exist and not be detected by this particular misexpression assay. Finally, the use of
animals heterozygous for mutations may not have sufficiently reduced the function of the
genes tested to alter the Socs44A misexpression phenotype. Clearly, this assay was
designed to detect dominant interactions; therefore, negative data cannot be interpreted as
a lack of an interaction.
In the previous chapter, I showed that ectopic expression of Socs44A in clones of
cells at the posterior terminus of the developing egg chamber had no effect on the
posterior cell fate marker, pointed, suggesting that Socs44A does not downregulate
JAK/STAT signaling in oogenesis. Recent work in our lab showed that the JAK/STAT
pathway is responsible for establishing a cell fate pre-pattern exhibiting a symmetrical
mirror image during oogenesis (Xi et al., 2003). This symmetry is broken by Gurken,
expressed from the oocyte positioned in the posterior of the egg chamber, which activates
EGFR/MAPK signaling, resulting in the posterior cells adopting the appropriate terminal
cell fate (Gonzalez-Reyes and St Johnston, 1998; Roth et al., 1995). Thus, in order for
cells to adopt their proper terminal cell fates, both the JAK/STAT and EGFR/MAPK
pathways must be activated. This is evidenced by the failure of terminal cell fate
differentiation via ectopic EGFR induction in main body cells, where JAK is not active;
whereas success is seen in induction of EGFR induction in anterior cells, where JAK is
active (Xi et al., 2003).
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One could imagine that ectopic Socs44A has no effect on pointed expression
because its downregulation of JAK/STAT and upregulation of EGFR/MAPK cancels
itself out. This theory is dependent on incomplete reduction of JAK/STAT signaling by
Socs44A because complete abolishment of pathway activity would result in loss of
pointed expression, regardless of its effects on EGFR/MAPK signaling. If indeed, it was
incomplete reduction of JAK/STAT signaling, but still sufficient to pre-pattern the
terminal cells, we would expect to see cell autonomous ectopic pointed expression in
clonal cells, driven by Socs44A upregulation of EGFR/MAPK signaling. This was not
the case, as the gradient of pointed expression from the posterior terminus was unaffected
by induction of clones ectopicly expressing Socs44A. Therefore, we can conclude that
Socs44A is not capable of affecting JAK/STAT or EGFR/MAPK signaling in patterning
the terminal follicle cells of the ovary, at least to the sensitivity of the assay used. This
does not rule out roles in patterning other cell fates within the ovary. Furthermore, this
suggests that Socs44A regulation of EGFR/MAPK signaling might also be tissue
specific. Further clonal analyses will be required to validate the issues raised here.
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Figure 4-1. Socs44A increases activity of EGFR signaling. The ectopic wing vein
phenotype of Socs44A misexpression (A, arrow) is rescued by reduction of Egfr (B), Sos
(C) or Ras85D (D), all positive effectors of EGFR signaling. In contrast, reduction of
argos, a negative regulator of EGFR signaling, enhances the phenotype (E, arrows).
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Figure 4-2. Concurrent misexpression of Socs44A rescues argos misexpression in a
dose-dependent manner. Heteroallelic combinations of EGFR mutations result in loss
of the ACV and the medial portion of L4 (A). Misexpression using two copies of the
argos transgene results in loss of both crossveins and L4 (B, arrows). Concurrent
misexpression of Socs44A rescues this phenotype, resulting in a wing similar to the
EGFR double mutant (compare C and A, arrows). When a single copy of the argos
transgene is used (D), the Socs44A misexpression rescue results in a nearly wild-type
wing (E). All UAS constructs are driven in the posterior of the wing using one copy of
engrailed-GAL (en-GAL).
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Figure 4-3. Phenotypic classes generated by misexpression of argos. Misexpression
of argos via the engrailed-GAL4 driver produces a range of phenotypic classes,
categorized by the presence of the posterior crossvein (PCV) and L4. Left column
contains representative pictures of each class. Right column, corresponding description
used to score wings into the phenotypic classes. It should be noted that Class V and
Class VI phenotypes were only observed in animals where Socs44A and argos are
concurrently misexpressed.
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Figure 4-4. Socs44A deficiencies enhance argos misexpression phenotypes. A
deficiency (Df(2R)CA53, CA53) that includes the Socs44A locus shifted the distribution
of phenotypes to the more severe classes compared to a local deficiency that does not
include Socs44A (Df(2R)Drlrv18, Drl) or no deficiency at all (Scutoid, Sco). See Fig 4-3
for class definitions.
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Figure 4-5. Socs44A misexpression rescues argos misexpression phenotypes.
Concurrent misexpression of Socs44A (UAS-44A) rescues misexpression of argos,
shifting the distribution of phenotypes, producing Class V and Class VI wing phenotypes
(compare UAS-44A to Sco). Concurrent misexpression of GFP (UAS-GFP) did not
produce class V or class VI wing phenotypes. Misexpression of UAS constructs in the
posterior of the wing was achieved using the engrailed-GAL4 driver. For class
definitions, see Fig. 4-3.
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Table 4-1. Socs44A misexpression assay data.
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Mutants and transgenics were placed in the engrailed-GAL4; UAS-Socs44A
misexpression background. Wings were analyzed for suppression or enhancement of the
Socs44A misexpression phenotype. Several transgenes were lethal when misexpressed
with engrailed-GAL4; therefore interactions could not be determined (ND-lethal).
Concurrent misexpression of Socs44A rescued the phenotypes associated with engrailedGAL4 misexpression of hop (UAS-hop) and argos (UAS-argos).
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Chapter V
Attempts to isolate a loss-of-function Socs44A mutation
INTRODUCTION
Evidence presented in previous chapters suggests that Socs44A interacts with
multiple signal transduction cascades. However, these studies utilized misexpression
analysis of Socs44A function. While ectopic expression demonstrates the capacity of
Socs44A, it may also overestimate its functions, as elevated levels of protein or
inappropriate location of expression could result in non-specific interactions.
Misexpression studies of SOCS in mammals overestimated their physiological roles, as
was the case for SOCS-3 and SOCS-5. Initial misexpression studies of SOCS-3 indicated
that it might be a pleiotropic inhibitor of cytokine signaling as it is capable of regulating
multiple cytokines, including IL-10 (Alexander, 2002). However, STAT3 activation
induced by IL-10 was not enhanced in Socs3-/- macrophages. Misexpression of SOCS-5
indicated that it might be involved in T cell development and differentiation (Seki et al.,
2002); however, analysis of a recently generated SOCS-5 knockout indicated that it was
dispensable for these functions (Brender et al., 2004). Misexpression could also
potentially lead to a qualitative error in the misjudgment of Socs44A function, as was the
case for murine SOCS-2. When expressed at low levels, SOCS-2 inhibits growth
hormone signaling, but at higher levels, it actually stimulates GH signaling (Favre et al.,
1999). Finally, we have already demonstrated context specificity for Socs44A action that
is consistent with the mammalian model. Therefore, the interpretation of expression of
Socs44A out of context must be guarded.
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In the absence of an available mutant, we utilized several overlapping deficiencies
to study the loss-of-function of Socs44A. These deficiencies behaved consistently with
our expectations based on misexpression analyses. Nevertheless, these deficiencies are
quite large, removing multiple genes in addition to Socs44A (Table 5-1) that theoretically
could be responsible for the interactions we observed. Analyses utilizing a loss-offunction allele of Socs44A would not be plagued with these issues. It would allow for the
analyses of the endogenous activity of the protein in its appropriate context without the
ambiguity associated with the deletion of multiple genes. Therefore, to validate findings
presented in this work, several avenues designed to isolate a Socs44A loss-of-function
mutation were pursued. This chapter will discuss progress on these avenues.

RESULTS
P-element excision
The Drosophila P-elements are perhaps the best-studied eukaryotic transposons.
They are a widely exploited tool used by geneticists to manipulate the Drosophila
genome (Engels, 1997). The Drosophila community has developed several strategies for
targeted manipulation of the fly genome using a variety of P-elements (Cooley et al.,
1988; Parks et al., 2004; Sentry and Kaiser, 1992; Spradling et al., 1999; Thibault et al.,
2004; Timakov et al., 2002; Tower et al., 1993). These strategies are largely made
possible by the engineering of P-elements that lack the enzyme transposase, required for
excision and integration of the element (Beall and Rio, 1997; Beall and Rio, 1998; Doll et
al., 1989; Kaufman et al., 1989; Rio and Rubin, 1988). P-element induced mutagenesis
has allowed for the isolation of several components of the Drosophila JAK/STAT
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cascade. Marelle6346 (a synonym for stat92E) was recovered in a P-element mobilization
screen for autosomal zygotic lethal mutations exhibiting specific maternal effect
phenotypes (Hou et al., 1996). The Drosophila JAK/STAT receptor, domeless, was
identified in two separate screens of P-element insertions. The first was designed to
identify novel factors in posterior spiracle development (Brown et al., 2001). The second
screen sought modifiers of GMR-GAL4 driven misexpression of upd (Chen et al., 2002a).
Drosophila P-elements utilize cut-and-paste transposition generating a double
strand break in the chromosome (Engels et al., 1990; Gloor et al., 1991; Kaufman and
Rio, 1992) resulting in a variety of excision products (Gloor et al., 2000; O'Brochta et al.,
1991). Precise excisions involve removal of the P-element without affecting adjoining
DNA, although a P-element footprint is left behind (Engels et al., 1990; Nassif and
Engels, 1993). Imprecise or “dirty” excisions occur when the P-element removes
flanking DNA sequences when it is excised, resulting in a deletion surrounding the
original P-element locus (Gloor et al., 2000).
There are several characterized P-element insertions in the vicinity of Socs44A on
chromosome 2R (Fig. 5-1). We attempted to imprecisely excise one of these P-elements,
in hopes of deleting the Socs44A locus, generating a null allele. One of these elements,
KG03963, is homozygous viable and is located approximately 5 kbp upstream of the 5’
end of the Socs44A locus. This element contains the mini-white gene which permits the
rescue of white- mutants by tracking the P-element via the red eye color it imparts on the
animal (Roseman et al., 1995). This element was excised (see scheme, Fig. 5-2) using
∆2-3 (Robertson et al., 1988) as the source of transposase. Of 109 independent excision
events recovered, 102 remained viable, while 7 were lethal as homozygotes. The lethal
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excision events were then subjected to complementation analysis with lethal P-element
insertions that flank either side of Socs44A (Fig 5-1). All seven lethal excisions
complemented both P-elements, indicating that those loci remained intact in these
animals (Table 5-1). The lethal excision events were balanced over the P{Act-GFP}CyO
balancer, which ubiquitously expresses GFP under the Actin promoter. This allowed
recovery of DNA from homozygous embryos and larvae; DNA was collected from
homozygous adults (marked by lack of the CyO marker) for the viable excision events.
All 109 lines were then tested by PCR for the presence of the Socs44A locus (Table 5-1).
Specifically, the 5’ portion of Socs44A proximal to the KG03963 insertion site was PCR
amplified from animals homozygous for the excision. As a positive control, a portion of
the unpaired locus was simultaneously amplified for each line. For the lethal excisions,
selection of homozygous animals was confirmed by failure to PCR amplify GFP.
Furthermore, the intergenic region 5’ of Socs44A was also amplified from animals
presumed to have imprecise excision events (Fig. 5-1). These data indicate that all of the
excisions recovered failed to delete Socs44A.

EMS mutagenesis
Since its introduction in 1968, Ethyl methanesulphonate (EMS) has been the most
commonly used chemical mutagen in Drosophila genetics (Lewis and Bacher, 1968).
EMS is an alkylating agent that produces G/C to A/T transition class mutations (Pastink
et al., 1991). In theory, the standard 25mM dose of EMS will lead to a 1 in 1000
mutation rate for the average gene (Greenspan, 1997). However, there is considerable
variation to this estimate based largely on the size of the coding region and the number of
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critical amino acids in the gene target. Nonetheless, EMS mutagenesis screens have
successfully produced mutant alleles of several of the known Drosophila JAK/STAT
components. Mutations in hopscotch were recovered in a screen for maternal effect
lethal genes exhibiting segmentation defects (Binari and Perrimon, 1994; Perrimon and
Mahowald, 1986). The stat92EHiJak allele was isolated in a mutagenesis screen for
dominant autosomal suppressors of the hyperactive hopTum-l allele (Hanratty and Dearolf,
1993; Yan et al., 1996a). Upd alleles were isolated in an elaborate screen involving a
duplication of polytene segment 17 of the X chromosome placed on the Y chromosome
which allowed for the recovery and complementation analyses of zygotic lethal mutants
in that segment of the X chromosome (Eberl et al., 1992).
Our lab, in collaboration with several others, embarked upon a large scale F3 EMS
screen designed to isolate mutations of several genes located on the second chromosome:
Socs36E, Socs44A, StIP, and Ric. Socs36E and Socs44A have already been described in
detail within this text. StIP (Stat interacting protein) is a WD-40 repeat containing
protein that has been shown to interact with both JAK and STAT in mammalian systems.
Biochemical analyses suggest that it may serve as an adaptor molecule that facilitates
STAT recruitment to the receptor complex (Collum et al., 2000). Biochemical analysis
of Ric indicates that it is a small GTPase that binds Calmodulin (FlyBase Consortium,
2003; Wes et al., 1996). Ric has not been associated with JAK/STAT signaling in
Drosophila.
Starting with a line carrying an isogenized second chromosome containing
cinnabar (cn), brown (bw), and speck (sp) markers, 600 males were exposed to 25mM
EMS per the standard protocol (Ashburner, 1989). These males were then mated en
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masse to y w; Sco/CyO females. Of the progeny collected, 7,477 males were individually
mated again to three y w; Sco/CyO females. From these crosses, 3,986 balanced stocks
were recovered, each carrying a mutagenized second chromosome (the complete scheme
can be found in Fig. 5-3). Approximately 62% of these stocks were homozygous viable
for the mutagenized chromosome, assayed for by the presence of flies with wild-type
wings in the CyO balanced stocks. From this we can extrapolate that each mutagenized
stock carries 1.5 recessive lethal mutations on the second chromosome (Ashburner, 1989)
for a total of 5,979 lethal hits. Although the precise number of essential genes in the
Drosophila genome is not known, it has been estimated that approximately 3,600 genes
are essential (Miklos and Rubin, 1996). The second chromosome accounts for
approximately 40% of the entire Drosophila genome (Adams et al., 2000), thus
containing approximately 1,440 essential genes. To carry this line of reasoning further,
we would then expect that our screen hit each lethal gene on the second chromosome on
average 4.15 times, suggesting that we approached saturation.
While similar strategies were employed to isolate mutations in all four genes, I
will focus on our efforts to obtain loss-of-function alleles of Socs44A. There are several
deficiencies located in the vicinity of Socs44A (Fig. 5-4). These deficiencies were tested
by complementation with molecularly defined P-elements that flank either side of
Socs44A to determine which deficiencies uncovered the Socs44A locus. All 3,986
balanced stocks were crossed to the Df(2R)CA53 deficiency, which contains the Socs44A
locus, and tested for complementation. Those lines that failed to complement
Df(2R)CA53 were submitted to secondary screens against another deficiency that takes
out the Socs44A locus (Df(2R)NCX10) as well as deficiency that does not take out
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Socs44A (Df(2R)Drlrv18). Of the 3,986 lines, 42 lines failed to complement Df(2R)CA53
and Df(2R)NCX10 and successfully complemented Df(2R)Drlrv18 and were retained as
candidate Socs44A mutants.
Of the 42 candidate mutants, 4 were viable as homozygotes while the remainder
were lethal. None of the candidates exhibited dominant phenotypes. When crossed to a
Socs44A containing deficiency, four of the candidates displayed wing vein defects. Three
lines were marked by a loss in the most distal portions of L5, while one line had weak
ectopic wing veins that did not seem to be localized to a particular portion of the wing.
The remaining 38 lines were lethal when crossed to the Socs44A deficiency. All 42 of
the candidate mutants were crossed pair-wise in a complementation analysis to determine
the number of genes represented in the collection. The results of this analysis were not
easily interpreted as inconsistent complementation behavior was observed. These
behaviors may have been the result of semilethality, intergenic complementation, or some
other unknown phenomenon. Nonetheless, we estimate that there are no more than 23
complementation groups present in the Socs44A candidate collection (Table 5-2).
As detailed in the previous chapter, Socs44A interacts with the EGFR/MAPK
pathway. I developed an assay to test this interaction based on modification of the
distribution of phenotypes seen when argos is misexpressed using the engrailed-GAL4
driver. Deficiencies for Socs44A shifted the distribution to the more severe phenotypic
classes (Fig. 4-4). Loss-of-function mutants generated in the EMS screen would be
expected to behave in a similar fashion. Representatives from each of the 23
complementation groups were subjected to this argos misexpression interaction assay.
The distribution of phenotypes generated by each line was then compared to Df(2R)CA53
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as well as Sco using Fisher’s Exact Test (Armitage and Berry, 1994) and are presented in
Table 5-2 (statistical analyses courtesy of Chris Saunders). Of particular interest is
candidate 7267, of which we did not observe anything that would lead us to believe that
there is a statistical difference between its behavior and that of the Socs44A deficiency
Df(2R)CA53 (p = 1). Several other candidates showed interactions by this assay and are
identified in Table 5-2.
In addition to the argos interaction assay, representatives for several
complementation groups were selected for sequencing (Table 5-2). These lines were
balanced over the P{Act-GFP}CyO chromosome. Embryos and larvae that were
homozygous for the mutagenized chromosome were selected by virtue of their lack of
GFP fluorescence. The Socs44A locus was then PCR amplified from genomic DNA
isolated from these animals. Sequence analysis from these lines revealed no molecular
lesions within the amplified region when compared to the sequence of the original
isogenic cn bw sp chromosome.

DISCUSSION
This chapter chronicles efforts to obtain a loss-of-function allele of Socs44A. I
had hoped that the isolation of a Socs44A hypomorph would allow me to validate my
previous findings implicating roles for Socs44A in JAK/STAT and EGFR/MAPK
signaling. Furthermore, this reagent would be indispensable in determining the roles of
Socs44A in Drosophila development. Unfortunately, there are no guarantees when
undertaking random mutagenesis screens that attempt to target a specific gene for
mutation. I attempted both a P-element excision as well as a saturating F3 EMS screen
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against Socs44A deficiencies. Although not all of the candidates from the EMS screen
have been analyzed completely, recent developments in the Drosophila community
indicate it is impossible that our strategy would produce the desired mutation. These
implications will also be discussed.

P-element excision mutagenesis
I attempted to excise a viable P-element located approximately 5kb away from the
Socs44A locus. There are several variations of P-elements in use by Drosophila
geneticists, each of these elements exhibits different behavior in regards to the frequency
of excision and the class of the resulting molecular lesion produced by excision.
Furthermore, the location of the P-element insertion may also affect its behavior in these
regards (Gloor et al., 2000; Handler, 2001; Spradling et al., 1999). Of the 215 attempted
excisions, 109 independent excision events were recovered (excision evidenced by loss of
the white eye marker), indicating that 51% of the males gave rise to some progeny with
excision events. Of these events, 102 remained viable, while in the other 7, excision
resulted in homozygous lethality. It is likely that the vast majority of the 102 viable lines
represent precise excision events, as this phenomenon is often reported as the most
common P-element excision event (Gloor et al., 2000; Sentry and Kaiser, 1992). I can
presume that the seven lethal lines represent P-element excision events that were not
precise because the original KG03963 insertion is homozygous viable. PCR
amplification of genomic DNA from these animals revealed that none of these events
excised the Socs44A locus or the adjacent 5’ region. I can assume these excisions were
simply not large enough to remove Socs44A.
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Several labs have conducted imprecise excision screens using P as well as other
transposable elements and there is no consistency in the size or the rates in which
deletions are recovered. Johnson-Schlitz and Engels (1993) excised a P-element from the
white locus, generating 65 excision events. None of these deleted more then 905bp of
genomic DNA surrounding the insertion. In stark contrast, Mohr and Gelbart (2002)
excised P{wHy} from multiple locations on the second chromosome. This element is a
hybrid between P and hobo type transposons. They produced a total of 66 deletions (of
138 recombinants), of which 53 were greater than 10kb. In another excision screen,
Preston, Sved, and Engels (1996) excised P{CaSpeR}Cp150C, generating 243 recombinant
lines. Of these 21 were short deletions less than 650bp while 24 were much larger; the
largest measuring over 100kb by cytology. In this study, Preston et al noticed that the
breakpoints of the deletions often correspond to P-element insertion site preferences.
These include euchromatic regions often near the 5’ end of genes and target octamers
similar to sequence GGCCAGAC (Engels, 1989; Kelley et al., 1987; O'Hare and Rubin,
1983). This suggests that P-element mobilization behavior can be used as a guide for
imprecise excision activity. Thus, we would expect that the majority of deletions would
be small because P-elements preferentially mobilize to local sites within 2kb of the
insertion site (Tower et al., 1993), although 2 out of 36 mobilizations in the Tower et. al.
study moved as far as 128kb away.
Why did the P-element excision screen fail? The scope of the screen was well
within that of those describe above, all of which generated deletions larger than the 5kb
needed to remove Socs44A. However, it is known that P-elements tend to insert
themselves into “hotspots” in the genome (Spradling et al., 1999), which may have some
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bearing here because breakpoints apparently mimic insertion site preferences. Perhaps
Socs44A is not in a “hotspot” for the particular P-element used. Also, it is known that
there is directionality to the deletions caused by P-element excision (Preston et al., 1996).
It is possible that the starting P-element was not oriented in the proper direction for
efficient deletion of the Socs44A locus.
Although the P-excision screen failed to generate a Socs44A deletion, 7 lethal
lines were recovered. Based on complementation analyses, the breakpoints of these
presumed excisions fall between the l(2)k16504 – Socs44A interval (Fig. 5-1). This
genomic region is approximately 55kb and contains 13 genes. Of these, five genes have
been named while the others are predicted loci. One of these, CG11210, has been
disrupted by a P-element insertion and is lethal (Bellen et al., in press). This predicted
gene does not have any functionally characterized domains or motifs, nor has any
analyses been published on the mutant. Four of the 13 genes have mutant alleles reported
in FlyBase that are viable (FlyBase Consortium, 2003). The remaining seven genes
include sut1, sut2, and five predicted genes. It is likely that the lethal excisions created
contain a small deletion around the KG03963 insertion that includes CG11210 and/or one
or more of these loci.

EMS mutagenesis
In a large collaborative effort, an F3 EMS screen was undertaken to isolate
mutations in several genes on the second chromosome, including Socs44A. A total of
3,986 balanced lines were generated, each containing a unique mutagenized second
chromosome. Based on the assumption that the second chromosome contains
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approximately 1,400 essential genes, our screen should have hit each of these an average
of 4.15 times. This suggests that we should have isolated a mutation in Socs44A
provided that such a mutant would produce a discernable phenotype when placed over a
deficiency for the locus. This reasoning exposes a potentially fatal weakness in our
screening strategy. If a Socs44A null animal has no visible phenotype and is not essential
for viability, then it would be impossible to recover such an animal in our screen even
though we approached saturation of the genome. Based on studies using engrailedGAL4 misexpression of Socs44A we hoped that in lieu of lethality we might have
detected a wing vein defect in potential Socs44A mutants. Indeed, we recovered several
candidate mutants that lacked wing vein material in the posterior compartment near the
PCV, consistent with our expectations. However, this phenotype is likely caused by
another mutation within the Df(2)CA53 - Df(2R)Drlrv18 interval. The reasoning for this is
provided in the next section.
These results are consistent with a multitude of mutagenic screens, some of which
were designed to target JAK/STAT components directly. Many large scale EMS screens,
including the Nobel winning work of Christiane Nüsslein-Volhard and Eric Wieschaus,
that isolated most of essential the mutations that pattern the embryo did not recover a
Socs44A allele (Nusslein-Volhard, 1979; Nusslein-Volhard and Wieschaus, 1980;
Nusslein-Volhard et al., 1984). Other screens for female sterility (Schupbach and
Wieschaus, 1989; Schupbach and Wieschaus, 1991) or maternal effect mutants, one of
which isolated hopscotch (Nusslein-Volhard et al., 1987; Perrimon et al., 1989;
Schupbach and Wieschaus, 1986) also failed to isolate alleles of Socs44A. Erica Bach
spearheaded a screen for dominant modifiers of a GMR-GAL driven unpaired
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misexpression rough eye phenotype in an effort to uncover new interacting JAK/STAT
genes, but also failed to isolate a Socs44A mutation (Bach et al., 2003). A similar screen
for modifiers of GMR-GAL driven misexpression of argos also failed to isolate a
Socs44A mutant (Taguchi et al., 2000). The Hou lab at the National Cancer Institute,
which studies JAK/STAT signaling, recently attempted a P-element mobilization screen
targeting the second chromosome. They report the isolation of 2,355 second
chromosome insertions in 850 different genes, but they failed to produce an insertion in
the Socs44A locus (Oh et al., 2003). Another P-element mutagenesis of the second
chromosome isolated 2,711 independent insertions, none of which disrupted Socs44A
(Torok et al., 1993).
All twelve of these screens had the potential to identify alleles of Socs44A, but
none were successful. All twelve of these screens (this list is by no means exhaustive)
employed different strategies, be they various forward genetic approaches, modifier
screens, or P-element mobilizations/disruptions. Add to that list our labor intensive F3
EMS screen of 3,986 mutagenized lines against Socs44A deficiencies and my local Pelement excision screen.
Ultimately, an allele of Socs44A was found as part of a large scale transposon
mediated gene disruption project (Thibault et al., 2004). In this endeavor, a modified
lepidopteran transposon was successfully mobilized into the Socs44A locus. This
approach was successful for several reasons. First, it did not depend on an observable
phenotype; instead, transposon insertion sites were molecularly defined. Second, the use
of the PiggyBac transposon eliminated the insertional bias associated with P-elements
(Spradling et al., 1999). Although it has not been determined if PiggyBac has its own
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preferential insertion sites, it is clear that PiggyBac does not share the same “hotspots” as
P-elements. Finally, this disruption project benefited from vast financial resources and a
large number of personnel, permitting a scale not possible in previous screens.
Although it is unlikely that any of the candidate mutants from the EMS screen are
bona fide Socs44A alleles, I did recover several lines, 7267 in particular, that showed
significant enhancement of the argos misexpression phenotype (Table 5-2). Based upon
the failure to complement Df(2R)CA53 and success in complementing Df(2R)Drlrv18,
these lines contain mutations within the 44A3 to 44B6 cytological region. This region
encompasses approximately 120 kb of DNA and houses 22 genes in addition to Socs44A
(Lewis et al., 2002). Of these, 8 have been studied but none of these are known to be
involved in JAK/STAT or EGFR/MAPK signal transduction. The remaining 14 are
predicted genes that have not been studied (FlyBase Consortium, 2003). Interestingly,
one of the unknown genes is predicted to be an ARF GTPase activating protein (GAP)
based on sequence similarity. If this gene is involved in EGFR/MAPK signaling, we
could postulate that our EMS induced candidate mutations are at that locus and not
Socs44A.

Recent developments
With the completion of the Drosophila genome (Adams et al., 2000), there has
been increased effort in the generation of community-wide tools for genetic analysis of
Drosophila. Among these is the large scale P-element mobilization mutagenesis
spearheaded by several prominent labs in the fly community designed to disrupt each and
every gene in the genome (Bellen et al., in press). A similar large scale effort, conducted
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by Exelixis using a modified form of the lepidopteran PiggyBac transposon (Handler and
Harrell, 1999) successfully disrupted the Socs44A locus (Thibault et al., 2004). This
mutant was made available to the Drosophila community only few months prior to this
writing. The transposon insertion is located at the 5’ end of the locus and disrupts the
codon that encodes D28 (Fig. 2-4); suggesting that the allele is null. These animals are
homozygous viable as adults and do not exhibit any discernable phenotype.
There is a possibility that this disruption of the Socs44A locus is not equivalent to
a null allele. It is possible that a constitutive promoter within the transposon (Thibault et
al., 2004) might be facilitating the production of a functional Socs44A product, making
this a hypomorphic allele. Mutational analyses of mammalian SOCS genes discovered
that the 5’ end upstream of the KIR (see Fig. 2-1) are dispensable for function with
regard to SOCS-1 and SOCS-3 (Nicholson et al., 1999). Therefore, deletion and/or
alteration of the amino terminus of the protein may not have an effect on the function of
the protein. Yet animals heterozygous for the transposon insertion and the Df(2R)CA53
deficiency were also viable and presented no phenotypes (J. Rawlings, unpublished).
Another possibility is that the transposon insertion is a gain-of-function allele because the
PiggyBac transposon contains a UAS element which, although highly unlikely, could be
generating a weak ectopic expression even in the absence of a GAL4 driver. However,
when crossed to the engrailed-GAL4 driver, no ectopic wing veins (or any other visible
phenotype) were observed (data not shown). Furthermore, the modified PiggyBac
element also contains “splice-trap” and transcriptional silencing elements (Thibault et al.,
2004), which would presumably prevent any ectopic or leaky expression of the disrupted
gene
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Taken as it is, the PiggyBac transposon disruption of Socs44A has several
important ramifications. First, it is not likely that the PiggyBac insertion is causing leaky
or ectopic expression of Socs44A and given the composition of the transposon and its
point of insertion, the allele is most likely null. Therefore, it is likely that Socs44A is not
an essential gene that has a straightforward adult phenotype. Second, the EMS screen
was predicated on the ability to screen for mutations based on complementation to a
deficiency, meaning that we had to be able to observe a phenotype in the mutant. Since
the Socs44A disruption had no phenotype, it is highly unlikely that the candidate mutants
generated by the EMS screen are Socs44A mutants. Finally, even if the PiggyBac
insertion was not null, the most straightforward next step would be to conduct an
imprecise excision of this element, which would guarantee a null allele. However, the
PiggyBac transposon exhibits a remarkable efficiency in precise excisions (Thibault et
al., 2004), making this strategy moot.
Nevertheless, this transposon insertion merits further scrutiny. It may have an
adult phenotype not detected by direct visual observations. Furthermore, it could have
transient phenotypes present in earlier development. One possibility is that it could affect
somatic follicle cell populations in oogenesis, as this process is governed by multiple
signaling pathways including JAK/STAT and EGFR/MAPK. These pathways in
particular act to pattern various cell populations at the termini of developing egg
chambers (Beccari et al., 2002; Gonzalez-Reyes et al., 1995; McGregor et al., 2002; Roth
et al., 1995; Silver and Montell, 2001; Xi et al., 2003). Since these distinct populations
present specific cell surface markers, we could examine Socs44A mutant ovaries for
changes in the distribution and/or differentiation of these cell populations. Another
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possibility is that Socs44A could have an effect on larval hematopoiesis, which also
depends upon JAK/STAT signaling (reviewed in Evans et al., 2003; Luo and Dearolf,
2001; Zeidler et al., 2000). As in oogenesis, the specific larval blood cell populations
also present markers (Lebestky et al., 2000) that could be exploited to determine if a
Socs44A mutant has an effect on hematopoiesis. Although crystal cell derived melanotic
tumors associated with dominant gain-of-function hop alleles were not observed
(Hanratty and Dearolf, 1993; Harrison et al., 1995; Luo et al., 1995; Luo et al., 1997), it
is possible that Socs44A has roles in the development and differentiation of other blood
cell types. Examination of the distribution of blood cell types in Socs44A mutants would
address this issue.
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Figure 5-1. P-element map of the Socs44A region. (A) Genetic map of the Socs44A
region illustrating relative positions of genes and P-element insertions (marked by
arrowheads above and below the blue boxes). Socs44A (shown in red) is flanked on
either side by the lethal P-elements (red arrowheads) l(2)k16503, EP(2)2264, and
l(2)02045. The viable P-element insertion (green arrowhead) KG03963 was used in a Pelement excision screen designed to make a small deficiency at the Socs44A locus (see
text for more details). Each tick mark represents 10kb of DNA. (B) Enlargement of the
boxed region shown in A. PCR primers used for amplification of Socs44A and upstream
regions are indicated as bars above and below the scale bar. Each tick mark represents
500bp of DNA.
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Figure 5-2. Scheme for imprecise P-element excision screen. The stable source of
transposase, ∆2-3, was used to excise the viable KG03963 P-element. The element
contains the mini-white gene which confers red eye color. The actual P-element
excisions occurred in the germline of the 3rd generation. 109 excision events were
selected for by the loss of eye color and balanced over the CyO balancer chromosome to
establish individual stable stocks. Only the relevant chromosomes are shown and all
crosses were done in a w- background.
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Figure 5-3. EMS mutagenesis scheme. 600 isogenized cn bw sp males were
mutagenized with EMS (denoted by red asterisk). The scheme illustrates crosses to
generate balanced stocks, each possessing a unique mutagenized chromosome. Each of
3986 balanced stocks that were recovered were screened in the F3 generation using a
deficiency for the gene of interest.
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Figure 5-4. Deficiency map of the 43F – 44B region. Breakpoints of several
deficiencies in the vicinity of Socs44A were mapped by complementation to several lethal
P-elements that flank the Socs44A locus. Think bars represent the extent of the
deficiency as mapped by complementation. The thin bars represent the theoretical limit
of the breakpoint. Both Df(2R)CA53 and Df(2R)NCX10 deficiencies were found to
include Socs44A and were used to screen for potential mutants. The Df(2R)Drlrv18
deficiency does not include Socs44A and was used as a means to pare down candidate
mutants (see text for details).
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Table 5-1. Summary of P-element excision screen.

The viable KG0369 P-element was excised, generating 109 independent excision events,
of which 7 were lethal as homozygotes. All lethals complemented the nearby lethal Pelements k16503 and EP2264 (for relative positions see Fig. 5-1) delimiting the
outermost boundary of the presumed imprecise excision. The Socs44A locus was PCR
amplified from homozygous animals from all 109 lines indicating that all failed to excise
Socs44A. ND = not determined.

83

Table 5-2. Summary of EMS mutagenesis screen.
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Table 5-2, continued.
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Table 5-2, continued.
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Table 5-2, continued.
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Table 5-2, continued.
We isolated no fewer than 23 complementation groups (column one) in an EMS screen
for alleles of Socs44A. Second column lists the members of each complementation
group. An asterisk indicates which line(s) of that complementation group were subjected
to the argos interaction assay. Third column shows that distribution of wing phenotypes
in the argos interaction assay. The x-axis, from left to right, is class I – class IV. The yaxis is proportion of wings in each class; each gridline is 10%. Fisher’s Exact Test
(Armitage and Berry, 1994) was used to compare this distribution to that of Scutoid (Sco,
fourth column) and Df(2R)CA53 or Df(2R)NCX10 (Df, fifth column). The p value
indicates the probability that the candidate mutant phenotype distribution is similar to that
of Sco or the Socs44A deficiency. A p = 1 indicates we did not observe anything that
would lead us to believe that there is a difference in the distribution of phenotypes
between the candidate and Sco or the deficiency. Those lines that behaved like expected
Socs44A hypomorphs are indicated in red. Finally, the last column indicates which
members of the complementation group, if any, were sequenced.
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Chapter VI
Multi-BLAST: database query for multi-domain proteins or
coding regions
INTRODUCTION
The reverse genetic investigation of the three Drosophila SOCS proteins was
predicated on not only their possession of both an SH2 and SOCS domain, but also the
specific arrangement of those domains within their amino acid sequence. In fact, this
modular arrangement of domains was instrumental in data mining the Drosophila
genome for potential SOCS homologues. The consensus SOCS domain (Hilton et al.,
1998) was used in a tBLASTn query of the Drosophila genome. The results of this
search were queried again for the presence of an SH2 domain in upstream sequences.
This arduous task inspired the creation of Multi-BLAST, a novel post-processor of the
popular BLAST suite of algorithms, designed for the efficient retrieval of multiple
domain containing proteins from public databases. This chapter describes the design and
implementation of Multi-BLAST. Multi-BLAST is available at:
http://genome.kbrin.uky.edu/multiblast/
Protein structure and function has proven to be surprisingly modular; the domains
that a protein possesses confer its functions. By arranging domains in different
combinations and orientations, large numbers of polypeptides, each with unique
functions, are produced. This phenomenon occurs naturally via genome rearrangements
during evolution. Additionally, alternative splicing can create proteins differing in their
modular domain arrangement from a single primary transcript. Although there are a
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multitude of algorithms designed for the identification and retrieval of sequences by
similarity, the approach to protein and genome analysis that seemed lacking was a simple
method to identify proteins or coding regions based upon a specific modular design. In
silico efforts to analyze protein sequences based on modular architectures have produced
large databases of protein domains such as SMART-A (Letunic et al., 2004; Schultz et
al., 2000; Schultz et al., 1998) and Pfam (Bateman et al., 2000; Bateman et al., 2004),
and methods to effectively find these individual domains.
Perhaps the most widely used method to identify similar protein sequences or
coding regions is the BLAST suite of programs (Altschul et al., 1997). BLAST and
related programs attempt to find overall similarity by dynamically building local
alignments between a query and database sequences. This is accomplished by assigning
a positive score to an alignment based on matches and similarities while assigning a
penalty to mismatches and gaps. BLAST has limitations, especially when searching for
proteins with multiple domains. First, BLAST discriminates against smaller domains
because the BLAST score is length dependent, the longer the alignment, the better the
score. Second, BLAST will stop building an alignment if it encounters a large enough
span of dissimilarity to make continuing such an alignment cost prohibitive. For
example, if one conducts a BLAST search against the nr protein database for proteins that
contain both an SH2 domain and a SOCS domain by using mouse SOCS-1 (Accession
AAD53324) as a query, the results are predominantly records that contain only the SH2
domain, primarily because the SH2 domain is ~70 amino acids long, while the SOCS
domain is only ~40 amino acids. The long match to the SH2 domain is sufficient to
generate a high BLAST score, while matches to the SOCS domain generate lower scores.
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Although the desired sequences that contain both domains are in the long list of
hits, sorting this list is not trivial. Motif searching using tools like PHI-BLAST (Zhang et
al., 1998), Pfam, or the SMART database is a very powerful way to identify lists of
domain-containing sequences. Nevertheless, identifying particular modular arrangements
within proteins on that BLAST hit list is not trivial with the tools available. Additionally,
these resources do not address the fact that the relative location of domains within a
protein may be important to its function. Furthermore, when using motif searches like
SMART-A, the user is confined to using the domain definitions provided, preventing one
from inputting novel sequences into a query.
NCBI recognizes the need to identify proteins based on modular architectures; in
that vein, they created CDART (Geer et al., 2002). This program accepts a protein
sequence as a query and displays proteins with similar architectures. For CDART to be
useful it must know the definitions of the domains of interest and be able to recognize
those domains within the query sequence; one cannot search for novel domains and/or
architectures. Additionally, CDART defines similar protein architectures as those
proteins that have one or more similar domains to the query; the distance between
domains is not considered. Finally, CDART does not accept nucleotide queries, nor can
it perform searches against translated databases.
We designed a novel post-processor of the BLAST suite of programs, called
Multi-BLAST, which allows the user to query protein or nucleic acid databases for
multiple domain containing proteins or coding regions in which the domains are
separated by a user-defined distance. A set of CGI, JavaScript, and Perl programs collect
input from the user and conducts independent BLAST searches with user-defined
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parameters for each input domain. Then the program compares the results to identify the
sequences matching the modular design, and presents both the independent and combined
domain search results to the user. The user interface couples this algorithm with the
domain definitions of over 600 protein domains offered through the SMART-A, Pfam,
and NCBI Conserved Domain databases. This communication presents the features of
Multi-BLAST and illustrates how it improves upon the BLAST suite in identifying
multiple domain containing proteins in sequence databases.

METHODS AND IMPLEMENTATION
Domain definition
In order to utilize this modular domain concept in the Multi-BLAST program, we
first needed a domain definition. When classifying a protein domain, one compares it
with sequences of known domains. Various algorithms like Hidden Markov Models
(Eddy, 1998) have been used to classify protein sequences into domain families and to
include these in massive alignments that determine a domain’s consensus sequence
resulting in databases such as Pfam and SMART. Our method capitalizes upon these
databases and upon the flexibility of user input BLAST queries. Through the feature
termed CD (conserved domain) Search, NCBI maintains current information regarding
the domain definitions offered by these two databases. We therefore dynamically linked
Multi-BLAST to the CD-search service, allowing Multi-BLAST to offer an extensive list
of domains (either consensus or representative sequences) for use. Additionally, this
dynamic linking also allows Multi-BLAST to offer direct links to the associated
information regarding domains selected by the user. We realize that although the domain
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definitions offered are extensive, they are nonetheless incomplete and that representative,
rather than consensus, sequences are available for some domain definitions. Therefore,
the Multi-BLAST program also allows the user to input novel sequences in addition to, or
in lieu of, the predefined domain sequences offered. Furthermore, Multi-BLAST
provides methods for modification of domain definitions if needed. Taken together, we
believe that Multi-BLAST offers an unprecedented level of user control and flexibility in
designing a database query.

Use of the BLAST suite of programs
Rather than design a novel core database search algorithm, we used the BLAST
suite of programs for several reasons. First, the BLAST algorithms can effectively
identify each domain queried since the sequence similarity within a domain is likely to be
continuous. Second, the BLAST suite of programs is freely available and relatively easy
to install and implement. Third, the BLAST suite of programs is well recognized, widely
used, and accepted in the scientific community. Finally, the BLAST suite of programs
allows Multi-BLAST the opportunity to accept nucleotide and protein queries and
conduct searches against nucleotide, protein, and translated databases, providing the user
with the utmost flexibility.

The Multi-BLAST program
The core concept of the Multi-BLAST program is quite simple. Instead of
creating a single BLAST query containing multiple domains of interest, Multi-BLAST
conducts independent, simultaneous BLAST searches for each domain entered. Multi-
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BLAST currently accepts two domains in a single query. Each domain that is entered,
either predefined or user-defined, is BLASTed according to the parameters set by the
user. Multi-BLAST then compares the results for each search and compiles a list of
records that appear in both search results. The BLAST-generated alignments are then
compared between matching records against a set of range variables entered by the user.
By entering a set of range values, the user has control over the relative position of each
domain within positive results. The end result is that Multi-BLAST is flexible, efficient
and easy to use.

User interface
On the surface, the Multi-BLAST user interface appears similar to the BLAST
suite of programs (Fig. 6-1). The user can select various BLAST programs, databases,
and several advanced BLAST options including expect threshold, scoring matrix, and
word size. Beneath this, the interface is divided into two sections, one for each domain to
be queried. For each domain, the user has the option of using domain definitions from
the Conserved Domain Database (CDD) at NCBI (Marchler-Bauer et al., 2003)
consisting of SMART, Pfam and other NCBI annotated domains. The SMART domains
are organized based upon function or cellular location: signaling, extracellular, nuclear,
or others. The Pfam and NCBI domains are organized alphabetically. All domain lists
include a brief description of each domain; furthermore, each domain is dynamically
linked to the CDD at NCBI, allowing instant access to associated information on each
domain (descriptions, alignments, references etc). Next, a set of range values must be
entered. The range values serve two purposes. First, for queries against nucleotide
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databases this prevents ludicrous matches to large multi-gene records (e.g. Drosophila
chromosomes). Second, this feature allows the user some control over the modular
design of desired records retrieved by Multi-BLAST. Finally, the user has the option to
have results sent via e-mail or to run the query interactively. The current version of this
service runs on a BLAST server at the University of Kentucky with databases updated
monthly. The simple code could be installed on essentially any BLAST server.
Results page
The results page generated by Multi-BLAST is divided into three parts (Fig. 6-2).
First, Multi-BLAST gives a summary of the query, including the program, database,
search parameters, and domains used. Second, Multi-BLAST offers links to the results of
each individual domain BLAST search. These two features are useful for
troubleshooting when no results are achieved from a given query. Finally, the user is
presented with a list of descriptions and alignments of records that matched the search
criteria for both domains. BLAST scores and Expect values are offered for each domain;
an asterisk denotes multiple matches within the user specified range to a given domain,
with the best BLAST score and E value reported. For example, the Drosophila dock
protein contains three tandem SH3 domains and an SH2 domain. All of the SH3 domains
that fall within the user specified range are shown in the alignment section, ranked by
BLAST score with the best score and E value reported in the descriptions section along
with an asterisk.
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RESULTS
To test the ability and efficiency of Multi-BLAST, we compared the results when
using both BLASTp and Multi-BLAST when querying NCBI databases for modular
protein sequences. For each standard BLASTp search, a protein containing two known
domains was used as a query; the Multi-BLAST query contained the appropriate domain
representations provided by Pfam and/or SMART using a reasonable distance variable.
In both types of searches, all parameters were set to default with the exception of the
number of records to display in the results, which was set to maximum in all searches.
Multi-BLAST was extremely efficient in recovering protein sequence records
containing both query domains (Table 1). All relevant two-domain proteins were
recovered in every case. In at least one case (AAF00543 query of the nr database),
Multi-BLAST recovered protein sequences that contain both domains but were not
recovered in the standard BLASTp search. This was probably due to the fact that
BLASTp search results depended on the particular query protein sequence in its entirety,
but that Multi-BLAST results depended only on the domain definitions.
Generally, using a known homologue in a BLASTp search is the most efficient
means to collect sequences that have a match to the domain architecture of the query.
This strategy does not work as well when domains are not spaced exactly like the query
or when the relative positions of domains differ from what is in the query sequence.
Furthermore, in most cases, similarity to one domain is sufficient for a record to be
included in the results. The end result is that along with desired records that contain both
domains, the results page contains records that have only one of the query domains. For
example, consider the SH2 and SH3 cell signaling domains found in most organisms,
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including Drosophila melanogaster. To access all Drosophila protein sequences at NCBI
containing both of these domains using a BLASTp strategy, one might use the Drosophila
GRB2 homologue (DRK) as a query. DRK is an adaptor protein in the Ras/Raf signaling
cascade that contains an SH3-SH2-SH3 modular architecture of these domains (Olivier et
al., 1993). By using this protein, the chances of obtaining records with both domains in
both possible orientations are optimized. The BLASTp search yielded 139 hits; upon
closer inspection, only twelve of these hits actually contained both SH2 and SH3
domains. Furthermore, these twelve hits are not the first twelve presented. Indeed, one
must look through the first 28 hits to find all twelve bona fide SH2 and SH3 domaincontaining protein sequences. When a Multi-BLAST search is conducted against the
Drosophila genome using the SH2 and SH3 domain representations from either SMART
or Pfam with default parameters, the correct twelve (and only those twelve) results are
displayed (Table 6-1). Similar results can be obtained using less promiscuous domain
combinations. SOCS proteins (suppressor of cytokine signaling) are involved in the
negative regulation of the JAK/STAT signal cascade. In addition to an SH2 domain, all
SOCS proteins contain a novel carboxy-terminal SOCS domain. Eight mammalian
SOCS proteins have been identified (Rawlings et al., 2004). To identify putative
Drosophila SOCS homologues, one can use murine SOCS-1 as a query for a BLASTp
against the Drosophila genome. This search yields fifteen hits, only two of which contain
both SH2 and SOCS domains. A similar Multi-BLAST search using those domains
yields just the two correct hits found using BLASTp. These examples, as well as similar
searches using other domain combinations against different databases are illustrated in
Table 6-1.
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DISUCSSION
Multi-BLAST is a novel post-processor of the BLAST suite of programs designed
to enhance its ability to find specific modular arrangements of protein domains within a
protein or nucleic acid database. A common approach to searching databases for
particular proteins using BLAST programs is to input a known homologue of the protein
of interest. This approach is not efficient in acquiring desired records of specific modular
proteins from protein databases. Many factors contribute to the appearance of “false
positives”, proteins without the intended domain architecture, in the results of BLAST
queries. Similarity to one domain is often sufficient to garner a favorable BLAST score
and it is not trivial to sort through the results to retrieve only the records that fit the
intended modular query. Also, BLAST does not take into account the orientation of
domains or distance between domains, both of which may be relevant to a particular
search. In both of these instances, BLAST considers each portion as a separate database
“hit.” For example, if one uses the Drosophila VAV protein as a BLASTp query for
other Drosophila proteins containing both an SH2 and SH3 domain, obvious matches
such as Src49A and RasGAP receive low BLAST scores (30 for both) and Expect values
(4.1 and 5.1, respectively) simply because the SH2 and SH3 domains of these proteins
are in the opposite orientation as in the query, with the BLAST score reflecting the match
to the best portion, not both domains. Furthermore, proteins like the Drosophila SL
protein which contain the SH2 and SH3 domains in the proper orientation are “false
negatives” in that they receive poor BLAST scores because the distance between domains
differs from the query. In the case of SL, which appears in the middle of the results list
(#30 out of 97 against Drosophila database; #472 out of 1172 against nr database), the
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BLAST score (35, Expect 0.083) is based only on its SH2 domain. Also, domains that
tend to be repeated within a protein sequence, such as Cadherin repeats, can cause
problems in obtaining desired records since the repeated elements are enough to generate
a high enough BLAST score making other domains present in the query insignificant (see
Cadherin and Laminin G query, Table 6-1). Multi-BLAST takes all of these issues into
account giving the user the utmost flexibility and control in designing database queries.
By conducting independent BLAST searches, each domain is given equal weight in the
results. The use of a range value allows the user to gain further control over which
records are included in the results and also prevents multi-gene containing records such
as cosmids or Drosophila chromosomes from being included in the results.
The Multi-BLAST program takes advantage of three publicly available lists of
domain definitions (SMART-A, Pfam, and NCBI). It is important to remember that
many of these domain definitions are representative sequences, not consensus sequences.
One can access the Conserved Domain Database (CDD) information on each domain
selected. From here, one can access the alignments used to generate the representative
sequences. Also, when a protein domain is selected, the sequence appears in the query
box. This gives the user flexibility to make any modifications to the domain sequence
before the search is executed. Finally, Multi-BLAST gives the user the opportunity to
enter novel or undefined sequences in lieu of or in addition to the domain definitions
provided.
This communication illustrates the use of Multi-BLAST in searching protein
sequence databases with protein queries; however, Multi-BLAST can use the entire suite
of BLAST programs, with the exception of PHI/PSI-BLAST. Although PHI/PSI-BLAST
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offers distinct advantages over the traditional suite of BLAST programs; these programs
were not included in Multi-BLAST because of their limitation to protein queries and the
need for iterative searching of both domains. The basic comparison algorithm could be
extended to include these programs, however.
Multi-BLAST has several limitations, some of which will be examined here.
First, it only accepts two domains in a query. It may be beneficial to add a third domain
to the query, especially when searching large databases with one or more promiscuous
domains. However, this would dramatically increase the complexity and speed of the
algorithm because domain order would have to be considered. Second, Multi-BLAST
cannot execute Boolean (AND, OR, NOT) type searches with the input domains. This
feature would allow for more complex queries making new types of sequence searches
possible. Third, Multi-BLAST could be improved by the inclusion of more of the
standard BLAST parameters and formatting options, most notably, “limit by Entrez
query.” This command allows results to be limited to subsets of the search database. All
of these improvements represent logical extensions of the present version of MultiBLAST and could be implemented into the program.
The uses of Multi-BLAST extend past simple sequence retrieval. With the
tBLASTn option, it is possible to use Multi-BLAST in genefinding, although we did not
test this specifically. One can also use Multi-BLAST to search for genetic elements that
are arranged in tandem (e.g. promoter elements), giving the Multi-BLAST program
additional utility. By far, the most promising and ambitious application of Multi-BLAST
lies in genome analysis. Evolutionary changes in genomes are, at least in part,
accomplished through sequence change including the creation of new and the
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rearrangement of existing functional domains. By using Multi-BLAST to query for every
possible combination of domains one could address questions genomic scale. For
example, Multi-BLAST could be used to determine which domain combinations are
unique to a particular organism or conserved within a group of organisms. By comparing
multiple genomes, it may be possible to decipher the core proteome of life. However it is
utilized, Multi-BLAST offers an efficient means to identify specific domain architectures
within the ever-growing databases of sequence information.
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Figure 6-1. Multi-BLAST user interface, input screen. Multi-BLAST user interface
on which an example of the drop-down domain selection menu has been activated for
domain 1. After selecting the domain, its sequence is displayed in the text box and can
be modified by the user.
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Figure 6-2. Multi-BLAST user interface, results page. Top is a summary of the user
query, including the program, database, query sequences and range value. Beneath the
summary is a list of records that match the query along with BLAST scores and Expect
values. An asterisk by the BLAST score indicates that multiple domains within the
sequence matched the domain query; only the highest BLAST score is reported. Beneath
the results summary are the alignments of domains within the first record to the domains
used in the query.
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Table 6-1. Comparison of Multi-BLAST and BLASTp.

Similar searches using Multi-BLAST and BLASTp were conducted and results
containing the domains of interest are reported. S_TKc, Serine threonine kinase catalytic
domain; FHA, Fork-head associated domain; LamG1, Laminin G domain; CA2,
Cadherin repeats; SH2, Src homology 2; SH3, Src homology 3; RhoGEF, Guanine
nucleotide exchange factor for Rho/Rac/Cdc42-like GTPases; SOCS, SOCS box; TyrKc,
Tyrosine kinase catalytic domain.
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Chapter VII
Conclusions and Discussion
In this work, I described the identification and characterization of Socs44A, a
presumed negative regulator of the JAK/STAT signal transduction pathway. I showed
that although Socs44A is not responsive to JAK/STAT pathway activity, it is capable of
downregulating the pathway in a tissue specific manner. Furthermore, I illustrated a
positive role for Socs44A in regulating the EGFR/MAPK pathway. This work also
chronicled the ongoing efforts to isolate a loss-of-function mutation in the Socs44A locus.
Finally, I presented a novel BLAST post-processor called Multi-BLAST that efficiently
retrieves multiple domain containing sequences from public databases.

The Drosophila genome encodes three SOCS homologues
Drosophila melanogaster presents an attractive model for the study of the
JAK/STAT pathway because its pathway is much simpler than its mammalian
counterparts. While the mammalian version of the pathway consists of numerous ligands
and receptors, four JAKs and seven STATs, the Drosophila version possesses but one
characterized homologue of each component required for pathway activation.
Furthermore, the Drosophila genome contains only one PIAS (Protein Inhibitor of
Activated STAT) homologue, zimp, compared to four mammalian homologues (Betz et
al., 2001; Hari et al., 2001; Mohr and Boswell, 1999). PIAS proteins negatively regulate
the pathway by interacting with and degrading STAT dimers, preventing their
translocation to the nucleus (reviewed in Wormald and Hilton, 2004). In this work I
describe the characterization of one of three Drosophila SOCS homologues that were
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identified on the basis of a shared modular domain architecture with the eight known
vertebrate SOCS. The presence of three fly SOCS genes raises an interesting question.
If the Drosophila JAK/STAT pathway is so much simpler than its mammalian
counterpart, why does the fly genome encode three SOCS?
One explanation is that the three Drosophila SOCS are redundant in function. We
know that this is not entirely true because Socs36E and Socs44A appear to have
differential functions in oogenesis. Furthermore, I show that Socs44A has an opposing
role to Socs36E in EGFR/MAPK signal regulation in the wing. Also, the mRNA
expression patterns of Socs36E and Socs44A do not overlap in either embryogenesis or
oogenesis. Finally, it appears that Socs44A lacks the capacity to respond to JAK/STAT
signaling. Taken together, these observations suggest that Socs36E and Socs44A are not
functionally redundant. The third Drosophila SOCS homologue, Socs16D has not been
functionally characterized. It is possible that it is redundant with one or both of the other
Drosophila SOCS. Once mutants for all three of these genes are isolated and
characterized, potential redundancies among these homologues can be addressed.
Another explanation for multiple SOCS genes in the Drosophila genome is that
these genes are more generalized regulators of signal transduction, not specific to
JAK/STAT. The possession of an SH2 domain would allow SOCS molecules to
theoretically interface with any signal transduction pathway propagated by tyrosine
phosphorylation. In vertebrates, various SOCS proteins have been shown to interact with
Vav, the Rho family guanine nucleotide exchange factor (De Sepulveda et al., 2000);
RasGAP, the Ras family GTPase activating protein (Cacalano et al., 2001); FAK, the
focal adhesion kinase (Liu et al., 2003); c-kit, a tyrosine kinase receptor (Bayle et al.,
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2004); and the Pim family of serine/threonine kinases (Chen et al., 2002b; Peltola et al.,
2004). This pleiotropy extends to Drosophila as we found that Socs44A genetically
interacts with and upregulates the EGFR/MAPK pathway. Our findings indicate that
Socs44A operates in an opposite fashion to Socs36E which was found to weakly suppress
EGFR/MAPK signaling (Callus and Mathey-Prevot, 2002).
Yet a third possibility is that, like their mammalian counterparts, Drosophila
SOCS are context specific. In mammals, this can be seen in the tissue specificity in
which SOCS genes can be induced. When growth hormone is injected into the murine
liver, CIS, SOCS-2 and SOCS-3 expression is induced; however, only CIS and SOCS-2
expression is induced in mammary glands (Davey et al., 1999). Unlike Socs36E, the
pattern of Socs44A expression in the embryo was not altered upon misexpression of
unpaired. It may be possible that Socs44A transcription could be induced by unpaired in
other tissues.

Role of Socs44A in JAK/STAT signal transduction
The hallmark of mammalian SOCS is their ability to both respond to and
downregulate the JAK/STAT cascade, forming a classical negative feedback loop. In this
work, I show that Socs44A expression is not responsive to or dependent upon the
JAK/STAT pathway. Furthermore, in the absence of a characterized Socs44A mutant, the
data presented herein are comprehensive lines of evidence that clearly suggest that
Socs44A has a role in downregulating JAK/STAT activity in the wing. One explanation
for the aberrant negative feedback loop participation is that the ability to respond to
pathway activation arose after the evolution of Socs44A. All of the mammalian SOCS
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have been shown to be responsive pathway activation, with the exception of SOCS-4,
SOCS-6, and SOCS-7. Interestingly, Socs44A occupies the same phylogenetic clade as
SOCS-6 and SOCS-7 (Fig. 2-2), consistent with this hypothesis. The third Drosophila
SOCS homologue, Socs16D, also belongs to this clade. It would be interesting to see if it
is responsive to JAK/STAT pathway activation. Another explanation for these
observations is that at some point Socs44A lost the capacity to respond to pathway
activation.
In addition to Drosophila melanogaster, JAK/STAT components can be found in
several invertebrate model organisms; however, these models do not contain a complete
pathway (Rawlings et al., 2004). The slime mold D. discoideum has three STATs but no
other components and the nematode C. elegans has both a STAT and a SOCS
homologue, but no JAKs, receptors, or ligands. The mere presence of a SOCS in C.
elegans suggests that the “original” function of SOCS proteins may not have been to
downregulate JAK/STAT signaling because the C. elegans genome does not contain any
of the known targets for SOCS-mediated downregulation of the JAK/STAT pathway. If
not JAK/STAT signaling, perhaps the “original” function of SOCS is to regulate another
cascade and interactions with JAK/STAT components arose with the divergence of
mammals. Phylogenetic analysis of known SOCS proteins is consistent with this
hypothesis, as all four of the mammalian SOCS genes that have been shown to both
respond to and downregulate the JAK/STAT pathway fall into a single clade not
populated by SOCS from either Drosophila or C. elegans (Fig. 2-2).
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Role of Socs44A in EGFR/MAPK signal transduction
The JAK/STAT and EGFR/MAPK pathways are integrated at multiple levels
resulting in combinatorial control of signal transduction. Theoretically, this phenomenon
allows for increased complexity in the interpretation of extracellular signals. It has been
shown that each pathway can activate the other independent of the endogenous ligand.
EGFR can mediate the activation of STAT independent of JAK activation (David et al.,
1996; Leaman et al., 1996). Additionally, there are several phosphorylation sites on
STAT not used by the canonical JAK/STAT mechanism. Studies have shown that
STATs can be phosphorylated at a serine residue at the C-terminus by several MAPKs,
potentiating STAT activity (Decker and Kovarik, 2000). Likewise, IL-6 and GH can
activate MAPK via JAK-2, presumably by activating the Shc and GRB2 adaptor proteins
(Giordano et al., 1997; Yamauchi et al., 1997).
In this work, I discovered and investigated the interactions between Socs44A and
the EGFR/MAPK pathway, illustrating that Socs44A can act to upregulate the
EGFR/MAPK pathway. A recent study showed that SOCS-3 behaves in a similar
manner, achieving this task through targeted degradation of RasGAP (Cacalano et al.,
2001). This interaction requires the phosphorylation of SOCS-3 on a C-terminal tyrosine
within the SOCS domain. Socs44A does not contain a tyrosine at this position, instead
contains a glutamic acid which could mimic a constitutively phosphorylated state.
Biochemical analyses of Socs44A will be required to address this possibility.
Interestingly, it has been shown that Socs36E also interacts with the EGFR/MAPK
pathway; however, it appears to have an opposite role. Misexpression of Socs36E was
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able to weakly suppress wing vein phenotypes associated with several EGFR/MAPK
pathway mutants (Callus and Mathey-Prevot, 2002).

Crosstalk between the JAK/STAT and EGFR/MAPK pathways
As mentioned above, the complexity required for the countless number of signals
that must be generated during development and homeostasis can be achieved, in part,
through crosstalk among signal transduction cascades. Combinatorial control of gene
expression may serve to attenuate levels of transcription or perhaps interplay provides a
means of redundancy, contributing to the robustness of these signaling pathways. There
is evidence that the JAK/STAT cascade can interface with several other signaling
mechanisms. This is not surprising as phosphorylation-mediated activation is a common
theme amongst many pathways (for review, see Graves and Krebs, 1999). Of particular
interest is the EGFR/MAPK (Epidermal Growth Factor/Mitogen Activated Protein
Kinase) pathway. Like JAK/STAT, this cascade relies on phosphorylation for signal
propagation. Therefore, it is not entirely surprising that EGFR can activate STAT,
independent of JAK activation (David et al., 1996; Leaman et al., 1996). Furthermore,
STATs may be activated by serine phosphorylation that is also mediated by several
MAPKs (Decker and Kovarik, 2000). Conversely, IL-6 and Growth hormone can
activate the EGFR/MAPK pathway in addition to JAK/STAT (Giordano et al., 1997;
Yamauchi et al., 1998; Yamauchi et al., 1997). Also, it has been shown that JAK can
activate MAPK through the Pyk2 intermediary (Takaoka et al., 1999). The interplay
between EGFR/MAPK and JAK/STAT may not be limited to vertebrates. Recent work
in our lab demonstrated the combinatorial requirement of these cascades in patterning the
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follicular epithelium during oogenesis (McGregor et al., 2002; Xi et al., 2003), however,
the precise mechanism of this control has yet to be elucidated. Perhaps this is
accomplished through direct interaction between these pathways. If so, then both
Socs44A and Socs36E are attractive as mediators of this interaction. Although Socs44A
is not expressed in the ovarian follicle cells, its transcripts were seen accumulating in the
oocyte, where Gurken initiates the EGFR/MAPK pathway.

The role of Socs44A in wing vein development
Developmental biology, when reduced to its simplest form, is the patterning of a
field of cells. The Drosophila wing provides an excellent model to investigate this
process. It consists of specific wing vein pattern dispersed in a field of epithelial cells
that is two cell layers thick. The wing veins provide structural rigidity and also serve as
conduits for sensory axons, hemocites, and tracheal cells (reviewed in De Celis, 2003).
The wing veins consist of six longitudinal veins, two of which (L1 and L6) do not reach
the distal margin. Additionally, there are two transverse veins that that intersect
longitudials. The anterior crossvein (ACV) connects L3 and L4 and the posterior
crossvein connects L4 and L5.
The development of the longitudinal veins takes place in progressive steps that
establish vein location and identity. The Hedgehog, Notch, Wingless, EGFR/MAPK and
Dpp pathways all work synergistically in this process that begins in the imaginal wing
disc with the establishment of provein and intervein cell-fate decisions along with
establishing the anterior-posterior boundary (Crozatier et al., 2002; Williams et al., 1993;
Zecca et al., 1995). It is known that Hedgehog is responsible for patterning L3, L4, and
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the ACV (Methot and Basler, 1999; Mullor et al., 1997). EGFR/MAPK signaling is
responsible for patterning L4 (Garcia-Bellido et al., 1994; Schnepp et al., 1996). Finally,
Dpp regulates spalt gene complex expression which is responsible for positioning of L2
and L5 (de Celis and Barrio, 2000). Interestingly, it is not known what directs the
patterning and positioning of the posterior crossvein.
I have provided evidence suggesting that endogenous Socs44A acts to
simultaneously downregulate JAK/STAT and upregulate EGFR/MAPK pathway activity
in the wing. It is known that the EGFR/MAPK pathway is involved in the specification
of vein and intervein cell fates. Heteroallelic Egfr mutants lack the central portion of L4
(Fig. 4-2). Other EGFR/MAPK pathway mutants share consistent phenotypes (Guichard
et al., 1999; Sawamoto et al., 1994). While much is known about the roles of
EGFR/MAPK in specifying vein and intervein fates, the roles of JAK/STAT signaling in
wing vein development have not been determined. Nonetheless, mutations in either
Stat92E or hop exhibit a relatively subtle wing vein defect, marked by a small amount of
ectopic vein material protruding longitudinally from the posterior crossvein (Yan et al.,
1996a and Fig. 3-5).
A simple model for the role of Socs44A in wing vein development can be
generated based upon findings in this study (Fig. 7-1). In this model, Socs44A acts to
upregulate EGFR/MAPK activity, as evidenced by ectopic wing vein phenotypes caused
by Socs44A misexpression that can be modulated by EGFR/MAPK pathway mutants.
One can speculate that targeting RasGAP for proteosomal degradation is the modus
operandi of Socs44A upregulation of EGFR/MAPK signaling, leading to ectopic
specification of vein cell fate in an otherwise intervein territory. Biochemical analyses
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will allow scrutiny of this hypothesis. Once the roles of JAK signaling in wing vein
development have been elucidated, Socs44A regulation of that pathway in this context
can be addressed.

Other roles for Socs44A in Drosophila development
The pleiotropy of the relatively few signaling pathways accounts for their ability
to govern the multitude of developmental and homeostatic processes. As a likely
regulator of both JAK/STAT and EGFR/MAPK signaling, it would not be surprising to
find that Socs44A is involved in many contexts. Tracheal morphogenesis and
hematopoiesis stand out as two developmental processes that are attractive models for the
continued study of the roles of Socs44A in Drosophila development.
Tracheal development (for reviews, see Manning and Krasnow, 1993; Metzger
and Krasnow, 1999; Shilo et al., 1997) begins with the assignment of tracheal cell fates to
ten segmental clusters of cells on each side of the embryo approximately four hours after
fertilization. These cells will then give rise to the tracheal pits in which unpaired
expression can ultimately be detected (Harrison et al., 1998 and Fig. 3-1). The remainder
of tracheal morphogenesis occurs solely by cell migration leading to the formation of a
large tree-like structure. Over 50 genes have been found to play roles in tracheal
development (Metzger and Krasnow, 1999). Mutants of these genes exhibit varying
phenotypes ranging from migration defects to faulty cell fate decisions (for review, see
Zelzer and Shilo, 2000).
The JAK/STAT pathway is involved in tracheal development. In embryos that
lack hopscotch, the trachea is reduced, and what tissue remains is grossly malformed,
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failing to migrate properly (Fig. 3-2). Furthermore, the elusive JAK/STAT pathway
receptor, domeless, was first isolated based upon its posterior spiracle defect (Brown et
al., 2001). Subtle tracheal defects were also observed in the StatHiJak mutant (Yan et al.,
1996a). I detected expression of Socs44A in the trachea of late stage embryos; however,
its expression does not overlap that of unpaired, which is expressed at an earlier stage.
Misexpression of Socs44A using the breathless-GAL4 driver resulted in lethality (Table
3-1). Breathless is an FGF homologue required for the proper migration of tracheal cells
(Yan et al., 1996a). In addition to FGF the TGF-β and EGFR/MAPK pathways are
involved in the migration of tracheal cells, helping to determine the size and spacing of
primary branches {reviewed in \Metzger, 1999 #280}. The coordination of all of the
signaling cascades involved in patterning the trachea is poorly understood. Socs44A
could have a role in the coordination of JAK/STAT and EGFR/MAPK signaling during
the patterning of the trachea. In light of its expression pattern in embryogenesis and the
implication of JAK/STAT and EGFR/MAPK signaling in tracheal development, the
study of Socs44A in tracheal development should merit further consideration.
Perhaps hematopoiesis is the most studied developmental process involving
JAK/STAT signal transduction. Abnormal levels of pathway activity have been directly
implicated as causative agents in hematopoietic disorders including several leukemias
and immune disorders (Aringer et al., 1999; Bowman et al., 2000; Coffer et al., 2000;
Lacronique et al., 1997; Leonard, 1996; Ward et al., 2000). Recently, the JAK/STAT
cascade has also been implicated in the progression of rheumatoid arthritis (Ivashkiv and
Hu, 2003; Naka and Kishimoto, 2002; Naka et al., 2002). As negative regulators of
cytokine signaling, SOCS are inviting targets for gene based therapies. Indeed, SOCS
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involvement in the immune response has been well documented (see review by Kubo et
al., 2003). It has been proposed that SOCS-3 could be used in such a fashion to combat
inflammatory arthritis (Rottapel, 2001; Shouda et al., 2001).
The Drosophila hematopoietic system is primitive compared to its mammalian
counterpart; however, several mechanisms in the hematopoietic process are conserved
(Evans et al., 2003; Lanot et al., 2001; Lebestky et al., 2000). Perturbations in
JAK/STAT signaling have analogous effects to what is seen in mammals. The gain-offunction alleles, hopTum-l and hopT42 are well-characterized. Animals carrying either of
these dominant mutations exhibit reduced viability, enlargement of the lymph gland and
develop melanotic masses (Hanratty and Dearolf, 1993; Harrison et al., 1995; Luo et al.,
1995; Luo et al., 1997). These observations make hematopoiesis an attractive target for
study. Preliminary data involving ectopic misexpression, RNA interference (RNAi), and
the use of deficiencies indicate that Socs36E may suppress the hopTum-l phenotypes (G.
Rennebeck and J. Rawlings, unpublished). Clearly, JAK/STAT signaling is paramount
for proper development of hematopoietic lineages in both mammals and flies and perhaps
Socs36E and/or Socs44A may be regulating this process.

Closing remarks
I describe in this work the identification and initial characterization of a SOCS
homologue in Drosophila. Based on its domain architecture, we believed that Socs44A
would participate in a negative feedback loop to regulate JAK/STAT signaling.
Therefore, we initiated a reverse genetic study that revealed important information about
this gene and the process of its characterization. First, I provide the first example of a
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SOCS gene, vertebrate or invertebrate, that is not regulated by JAK/STAT activity (at
least in the tissues we tested). Although it is not known if SOCS-4, SOCS-6, and SOCS7 are induced by cytokines, no one has shown that these molecules are not
transcriptionally regulated by the pathway. This important find illustrates the relevance
of negative data and the simplicity of the Drosophila JAK/STAT model, which allows
this claim to be made. Second, this work is the first to demonstrate differential tissue
specificity of SOCS activity in Drosophila, a phenomenon seen in the mammalian model.
This bolsters the validity of the insect as a model to study JAK/STAT regulation via
SOCS. Because the rest of the JAK/STAT pathway is much simpler in Drosophila,
future study in the dipteran could elucidate the mechanisms underlying this complexity.
Third, I discovered that Socs44A upregulates EGFR/MAPK signaling in wing
development in contrast to Socs36E which weakly suppressed it (Callus and MatheyPrevot, 2002). This is the first evidence of SOCS having direct opposing roles in any
developmental process. Fourth, our futile attempts at obtaining a Socs44A loss-offunction allele uncovered weaknesses in the reverse genetic approach to the investigation
of gene function, exposing the principle deficiency in Drosophila melanogaster as a
genetic system, specifically, the lack of efficient, rapid, targeted gene disruption.
Although a method for gene targeting has been recently developed (Rong and Golic,
2001; Rong et al., 2002), its efficiency and efficacy is largely untested. Fortunately,
efforts from the Drosophila community, namely Exelixis (Thibault et al., 2004) and the
BDGP (Bellen et al., in press) are addressing this flaw by attempting to disrupt every
gene in the genome through transposon mobilization.
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It is clear that SOCS play pivotal roles in the regulation of at least two signal
transduction cascades. I have shown that this regulation extends to the lower eukaryote,
Drosophila melanogaster. For years, Drosophila has been a pioneering model for
genetic investigation of developmental processes and my work regarding Socs44A
illustrates the utility of the fly as a model system. Clearly, this work has presented as
many, if not more, questions than it has answered. Is Socs44A responsive to JAK/STAT
signaling in other tissues? What are the precise roles of Socs44A and JAK/STAT
signaling in wing development? Is Socs44A involved in tracheal morphogenesis and
hematopoiesis? How? Most importantly, is our understanding of Socs44A and its roles
in signal transduction applicable to the human condition? Time will tell.
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Figure 7-1. Model for Socs44A involvement in wing vein formation. Based on
findings presented in this work, we can postulate that the ectopic wing venation caused
by Socs44A misexpression is the result of ectopic upregulation of EGFR/MAPK
signaling. This may be caused by Socs44A-mediated proteosomal degradation of
RasGAP. Based on distinct wing phenotypes exhibited in hop and stat92E mutants, the
JAK/STAT pathway also participates in patterning the wing veins, although its specific
role has yet to be determined.
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Chapter VIII
Materials and Methods
Fly strains
Fly strains were raised under standard conditions at 250C unless otherwise stated.
Sty alleles and Egfrtop1 were obtained from M. Freeman. Btl-GAL4 was obtained from
M. Krasnow. Pnt-LacZ was obtained from T. Schupbach. [Act5C>y>GAL4][UASGFP.S65T] was obtained from M. Zeidler. A Bgl I/Xho I fragment from LP02169
(described below) containing the entire Socs44A EST sequence was subcloned into the
pUAST vector (Brand and Perrimon, 1993) in order to ectopically express Socs44A in the
GAL4/UAS system. The resulting construct was used in standard germline
transformation (Spradling, 1986). Three independent insertions recovered and balanced.
All three behaved similarly when misexpressed with GAL drivers (Table 3-1). The
remaining GAL4 drivers (Table 3-1); mutants and recombinants used in Socs44A
interaction studies (Table 4-1); the Df(2R)CA53, Df(2R)Drlrv18, and Df(2R)NCX10
deficiencies; and the KG03963, EP(2)2264, and l(2)02045, and l(2)k16503 P-elements
are all described in FlyBase.

Cloning of Socs44A
An 1133bp fragment of genomic DNA corresponding to the Socs44A locus was
PCR amplified using the following primers: ‘5 – GAG CCA CGG CGA CCA GAG
TCA AAA A – 3’ and 5’ – CAA GTA CTC CAG CAT CTG CGC C – 3’. The resulting
product, pBS-Socs44Agenomic, was cloned into pBlueScript II KS+. Socs44A was also
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subcloned from the LP02169 EST clone (described below) as a Bam HI/Xho I fragment
and placed into pBluescript II KS+, making pBS-Socs44A. These constructs were used
in the in situ hybridizations to embryos, DNA sequencing and RNAi construction
described below.

Sequencing of the Socs44A EST
The Sanger/dideoxy method (Sanger et al., 1977) of nucleotide determination was
used to sequence the entire LP02169 EST sequence corresponding to Socs44A. The
following primers (obtained from IDT) were used (see Fig. 2-4):
#1: ‘5 – GAG CCA CGG CGA CCA GAG TCA AAA A – 3’
#2: ‘5 – CCA TGG GCG ACT GCG ACG ACG G – 3’
#3: ‘5 – CCG TCG TCG CAG TCG CCC ATG G – 3’
#4: 5’ – CAA GTA CTC CAG CAT CTG CGC C – 3’
#5: 5’ – CTT CTC CCT GTC CCT C – 3’
#6: 5’ – GCC GCC GTG TTC TGC – 3’
#7: 5’ – CCA TGC AAT CTA GAT TAG C – 3’
Additionally, standard primers corresponding to the T3 and T7 promoter sequences of
pBlueScript II were used. The sequence of this Socs44A EST has been deposited in
Genbank (Accession AF439523).

In situ hybridization
In situ hybridization of embryos and ovaries was performed essentially as
described (Harrison et al., 1998; Wilkie et al., 1999). Sense and anti-sense digoxigenin
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probes from the previously described Socs44A cDNAs were generated. Probe for
Socs36E was generated from the 5’ end of the 2.1.1 cDNA. Embryos aged 0-24 hours
were collected, dechorionated in 50% bleach, fixed in 3.7% formaldehyde and
dehydrated in methanol and stored until ready for use. Embryos were rehydrated in PBT,
fixed again in 3.7% formaldehyde, washed 5 x 5’ in PBT. Embryos were then moved
into hybridization solution (50% deionized formamide, 5X SSC, 50ug/ml heparin,
100ug/ml tRNA, and 0.1% Tween) and allowed to prehybridize for one hour at 700C.
Appropriate probes diluted between 1:200 and 1:50 and then hybridized overnight at
700C. The embryos were then washed for 20 minutes in prewarmed hybridization
solution at 700C followed by a 20 minute wash in prewarmed hybridization/PBT (1:1)
solution. Next, embryos were washed 4 x 20’ in PBT at 700C followed by 3 x 20’ washes
in PBT at room temperature. Embryos were then washed 3 x 5’ in pH 9 solution and then
developed in NBT and X-phosphate. The reaction was stopped by 6 x 5’ washes in PBT
+ EDTA. Embryos were mounted with 70% glycerol in PBT. All washes were done on
a standard microfuge tube rotator and incubations were done on a standard heating block.
Germline clone hopc111 null allele animals were generated using the dominant
female sterile technique (Chou and Perrimon, 1992). Embryos misexpressing upd in the
seven stripe pair-rule pattern were generated by crossing females carrying a UAS-upd
transgene with males heterozygous for paired-GAL4. Embryos were then collected and
hybridized as described.
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Immunological staining of embryos
Germline clone hopc111 mutants in a trh10512 enhancer trap background (Isaac and
Andrew, 1996) were generated. These animals (genotype hopc111/hopc111; trachealessLacZ/+) were stained with anti-β-gal antibody to visualize developing trachea (Patel,
1994). Briefly, embryos were dechorionated in 50% bleach and fixed in 3.7%
formaldehyde in heptane, washed in PBT, and blocked for 1 hour in 5% BSA in PBT.
Embryos were then incubated in a 1:1000 dilution of rabbit anti-β-gal overnight at 40C.
Following washes in PBT, embryos were then incubated in a 1:500 dilution of FITC antirabbit secondary antibody for 2 hours at room temperature. Embryos were mounted in
70% Glycerol, 2.5% DABCO in PBT.

Generation of ovarian clones
Ovarian clones of the hopc111 null allele were generated by mitotic recombination
mediated by hsFLP as previously described (McGregor et al., 2002). Misexpression
clones of Socs36E and Socs44A were generated using a GAL4 flip-out cassette, also
controlled by hsFLP (Ito et al., 1997). Genotype of those animals was w [hsFLP]1;
[Act5C>y>GAL4][UAS-GFP.S65T]/[UAS-Socs36E]11.2; pnt-LacZ and w [hsFLP]1;
[Act5C>y>GAL4][UAS-GFP.S65T]/+; [UAS-Socs44A]11D/ pnt-LacZ, respectively. For
each, ovaries were fixed and stained with anti-β-gal and anti-GFP as previously described
(McGregor et al., 2002).
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Misexpression studies
Flies carrying the [UAS-Socs36E] or [UAS-Socs44A] transgenes were mated to
various GAL4 drivers and compared to wild-type flies for any abnormal phenotypes. For
e16E, T113, T6, and ptc-GAL, wings were dissected and mounted in Hoyer’s medium
(Ashburner, 1989). Two copies of the [UAS-Socs36E] transgene were required to
generate the indicated wing phenotype when crossed to GAL-e16E (engrailed). For
interaction assays, flies of genotype y w; GAL-e16E/CyO; [UAS-Socs44A]11D/TM3 were
crossed to the mutant or recombinant listed in Table 4-1. In the argos interaction assay
of EMS mutants, flies of genotype [UAS-argos]/Y; GAL-e16E/[UAS-argos] were crossed
to each candidate Socs44A mutant in addition to y w; CA53/CyO, y w; NCX10/CyO, and
y w; Drlrv18/CyO. Female progeny possessing the X chromosome UAS-argos insertion,
the GAL-e16E driver, and the mutant/recombinant variable were examined. Each wing
on each animal was classified according to Fig. 4-3). Fisher’s Exact Test was performed
(courtesy of C. Saunders) on the data to determine statistical significance.

Image capture and processing
All in situ hybridization and wing images (Nomarski, DIC, and epifluorescence)
were acquired using a Spot Camera (Diagnostic Instruments) on a Nikon E800
microscope. A Leica TCS-SP laser scanning confocal microscope was used to capture all
confocal micrographs. All images were then exported to Adobe Photoshop for
manipulation and annotation.
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RNAi construction
pBS-Socs44A (described above) was cut with Xho I and Stu I, filled in with
Klenow and relegated to form pBS-Socs44A-5’-Stu. A 600bp Bam HI/Eco RI fragment
of pYES was subcloned into pBS-Socs44A-5’-Stu to form pBS-44A-spacer. A Sma
I/Xba I fragment of the EST clone, LP02169, was subcloned into pBS-44A-spacer via an
Xba/ blunted Bam HI ligation to create pBS-44A-hp6. An Xba I/Stu I fragment was
removed from this construct, the resulting DNA was blunted and relegated to form pBS44A-hp6.1. The entire symmetrical Socs44A inverted repeat was then isolated as a Kpn
I/Not I fragment and subcloned into pUASp (Rorth, 1998) to create the final construct
pUASp-Socs44A-RNAi.

EMS mutagenesis
Six hundred isogenized males of genotype y w; cn bw sp were fed 25mM EMS in
a 1% sucrose solution per the standard protocol (Lewis and Bacher, 1968). Mutagenized
males were then mated in groups of 8 to approximately 25 females of genotype y w;
Sco/CyO. 7,477 individual male progeny of genotype y w; cn bw sp*/CyO or y w; cn bw
sp*/Sco were then mated to three females of genotype y w; Sco/CyO (asterisk indicates
mutagenized chromosome). From each cross, siblings of genotype y w; Sco/CyO were
mated to establish a balanced stock. We recovered 3,986 balanced stocks. Each stock
was then mated to the CA53 deficiency and tested for complementation. Those stocks
that failed to complement (were lethal or exhibited a phenotype) were recrossed to CA53
for verification. Verified stocks were crossed to NCX10 and Drlrv18 deficiencies; stocks
that complemented Drlrv18 but failed to complement NCX10 were retained as candidate
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Socs44A mutants. Each of these stocks, a total of 43, were crossed pair-wise in
complementation analyses to determine number of genes represented in the collection.
Representatives of several of these groups were selected for sequencing. These lines
were balanced over the P{Act-GFP}CyO chromosome, permitting the collection of DNA
from homozygous animals based on their failure to fluoresce. Socs44A was PCR
amplified, sequenced, and scanned for molecular lesions by comparing this sequence to
the original, unmutagenized cn bw sp chromosome. Representatives of all of the groups
were subjected to the argos interaction assay described above.

P-element excision mutagenesis
The KG03963 viable P-element was excised in the germline of males of genotype
[KG03963]/CyO; ∆2-3,Sb/+. These males were crossed individually to y w; Sco/CyO
females and the progeny examined for excision based on loss of red eye color associated
with the P-element. Progeny of genotype [KG03963](w-)/CyO were mated to y w;
Sco/P{Act-GFP}CyO to establish 109 balanced stocks, each representing an independent
excision event. For each line, DNA was isolated from homozygous animals. In the case
of 7 lethal stocks, this was accomplished by selecting embryos or larvae that failed to
fluoresce. This process was verified by failure to amplify GFP from the DNA collected.
For all 109 stocks, a 700bp fragment of the upd locus (positive control) and a 400bp
fragment of the proximal portion of Socs44A were simultaneously amplified by PCR. In
parallel, a reaction containing all PCR reagents except template DNA was used as a
negative control. Finally, DNA from y w; Sco/P{Act-GFP}CyO flies was used as a
positive control for upd, Socs44A, and GFP amplification.
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Socs44A primers:
#1: ‘5 – GAG CCA CGG CGA CCA GAG TCA AAA A – 3’
#3: ‘5 – CCG TCG TCG CAG TCG CCC ATG G – 3’

Socs44A upstream primers:
S44-5’-1: 5’ – CTA GAG ATG GAA GTA TGT TCG – 3’
S44-5’-2: 5’ – GTG ATC AAT GCC TAA CTT TA – 3’

Unpaired primers:
Upd-54: 5’ CTG CAC ACT GAT TTC GAT ACG GAC CGC GG – 3’
Upd-798R: 5’ – GAT CCC AGC GGA TCT GCT GGC GCC – 3’

Bioinformatic analyses
All sequence alignments were done using AlignX (Informax Inc.) using ClustalX
parameters. The Phylogenetic trees were produced from the alignments using the
Neighbor-Joining method. All BLAST analyses were done at NCBI
(http://www.ncbi.nlm.nih.gov/BLAST) using the default parameters. All BLASTp
searches in the Multi-BLAST comparison also used default options, with the exception
that the number of results to display was set at maximum (1000) for each search.

127

References
Adams, M. D. Celniker, S. E. Holt, R. A. Evans, C. A. Gocayne, J. D. Amanatides, P.
G. Scherer, S. E. Li, P. W. Hoskins, R. A. Galle, R. F. et al. (2000). The genome
sequence of Drosophila melanogaster. Science 287, 2185-95.
Alexander, W. S. (2002). Suppressors of cytokine signalling (SOCS) in the immune
system. Nat Rev Immunol 2, 410-6.
Alexander, W. S., Starr, R., Fenner, J. E., Scott, C. L., Handman, E., Sprigg, N. S.,
Corbin, J. E., Cornish, A. L., Darwiche, R., Owczarek, C. M. et al. (1999). SOCS1 is
a critical inhibitor of interferon gamma signaling and prevents the potentially fatal
neonatal actions of this cytokine. Cell 98, 597-608.
Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W. and
Lipman, D. J. (1997). Gapped BLAST and PSI-BLAST: a new generation of protein
database search programs. Nucleic Acids Res 25, 3389-402.
Aringer, M., Cheng, A., Nelson, J. W., Chen, M., Sudarshan, C., Zhou, Y. J. and
O'Shea, J. J. (1999). Janus kinases and their role in growth and disease. Life Sci 64,
2173-86.
Armitage, P. and Berry, G. (1994). Statistical methods in medical research. Oxford ;
Boston: Blackwell Scientific Publications.
Ashburner, M. (1989). Drosophila: A Laboratory Handbook and Manual. Two volumes.
Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
Bach, E. A., Vincent, S., Zeidler, M. P. and Perrimon, N. (2003). A sensitized genetic
screen to identify novel regulators and components of the Drosophila janus kinase/signal
transducer and activator of transcription pathway. Genetics 165, 1149-66.
Barillas-Mury, C., Han, Y. S., Seeley, D. and Kafatos, F. C. (1999). Anopheles
gambiae Ag-STAT, a new insect member of the STAT family, is activated in response to
bacterial infection. Embo J 18, 959-67.
Bateman, A., Birney, E., Durbin, R., Eddy, S. R., Howe, K. L. and Sonnhammer, E.
L. (2000). The Pfam protein families database. Nucleic Acids Res 28, 263-6.
Bateman, A., Coin, L., Durbin, R., Finn, R. D., Hollich, V., Griffiths-Jones, S.,
Khanna, A., Marshall, M., Moxon, S., Sonnhammer, E. L. et al. (2004). The Pfam
protein families database. Nucleic Acids Res 32 Database issue, D138-41.
Bayle, J., Letard, S., Frank, R., Dubreuil, P. and De Sepulveda, P. (2004). Suppressor
of cytokine signaling 6 associates with KIT and regulates KIT receptor signaling. J Biol
Chem 279, 12249-59.

128

Beall, E. L. and Rio, D. C. (1997). Drosophila P-element transposase is a novel sitespecific endonuclease. Genes Dev 11, 2137-51.
Beall, E. L. and Rio, D. C. (1998). Transposase makes critical contacts with, and is
stimulated by, single-stranded DNA at the P element termini in vitro. Embo J 17, 212236.
Beccari, S., Teixeira, L. and Rorth, P. (2002). The JAK/STAT pathway is required for
border cell migration during Drosophila oogenesis. Mech Dev 111, 115-23.
Bellen, H. J., Levis, R. W., Liao, G., He, Y., Carlson, J. W., Tsang, G., Evans-Holm,
M., Hiesinger, P. R., Shultze, K. L., Rubin, G. M. et al. (in press). The BDGP gene
disruption project: single transposon insertions associated with 40% of Drosophila genes.
Genetics.
Betz, A., Lampen, N., Martinek, S., Young, M. W. and Darnell, J. E., Jr. (2001). A
Drosophila PIAS homologue negatively regulates stat92E. Proc Natl Acad Sci U S A 98,
9563-8.
Binari, R. and Perrimon, N. (1994). Stripe-specific regulation of pair-rule genes by
hopscotch, a putative Jak family tyrosine kinase in Drosophila. Genes Dev 8, 300-12.
Bowman, T., Garcia, R., Turkson, J. and Jove, R. (2000). STATs in oncogenesis.
Oncogene 19, 2474-88.
Brand, A. H. and Perrimon, N. (1993). Targeted gene expression as a means of altering
cell fates and generating dominant phenotypes. Development 118, 401-15.
Brawley, C. and Matunis, E. (2004). Regeneration of male germline stem cells by
spermatogonial dedifferentiation in vivo. Science 304, 1331-4.
Brender, C., Columbus, R., Metcalf, D., Handman, E., Starr, R., Huntington, N.,
Tarlinton, D., Odum, N., Nicholson, S. E., Nicola, N. A. et al. (2004). SOCS5 Is
Expressed in Primary B and T Lymphoid Cells but Is Dispensable for Lymphocyte
Production and Function. Mol. Cell. Biol. 24, 6094-6103.
Brown, S., Hu, N. and Hombria, J. C. (2001). Identification of the first invertebrate
interleukin JAK/STAT receptor, the Drosophila gene domeless. Curr Biol 11, 1700-5.
Cacalano, N. A., Sanden, D. and Johnston, J. A. (2001). Tyrosine-phosphorylated
SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Nat Cell
Biol 3, 460-5.
Callus, B. A. and Mathey-Prevot, B. (2002). SOCS36E, a novel Drosophila SOCS
protein, suppresses JAK/STAT and EGF-R signalling in the imaginal wing disc.
Oncogene 21, 4812-21.

129

Capdevila, J., Estrada, M. P., Sanchez-Herrero, E. and Guerrero, I. (1994). The
Drosophila segment polarity gene patched interacts with decapentaplegic in wing
development. Embo J 13, 71-82.
Casci, T., Vinos, J. and Freeman, M. (1999). Sprouty, an intracellular inhibitor of Ras
signaling. Cell 96, 655-65.
Chen, H. W., Chen, X., Oh, S. W., Marinissen, M. J., Gutkind, J. S. and Hou, S. X.
(2002a). mom identifies a receptor for the Drosophila JAK/STAT signal transduction
pathway and encodes a protein distantly related to the mammalian cytokine receptor
family. Genes Dev 16, 388-98.
Chen, X. P., Losman, J. A., Cowan, S., Donahue, E., Fay, S., Vuong, B. Q., Nawijn,
M. C., Capece, D., Cohan, V. L. and Rothman, P. (2002b). Pim serine/threonine
kinases regulate the stability of Socs-1 protein. Proc Natl Acad Sci U S A 99, 2175-80.
Chou, T. B. and Perrimon, N. (1992). Use of a yeast site-specific recombinase to
produce female germline chimeras in Drosophila. Genetics 131, 643-53.
Chung, C. D., Liao, J., Liu, B., Rao, X., Jay, P., Berta, P. and Shuai, K. (1997).
Specific inhibition of Stat3 signal transduction by PIAS3. Science 278, 1803-5.
Coffer, P. J., Koenderman, L. and de Groot, R. P. (2000). The role of STATs in
myeloid differentiation and leukemia. Oncogene 19, 2511-22.
Cohney, S. J., Sanden, D., Cacalano, N. A., Yoshimura, A., Mui, A., Migone, T. S.
and Johnston, J. A. (1999). SOCS-3 is tyrosine phosphorylated in response to
interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation. Mol
Cell Biol 19, 4980-8.
Collum, R. G., Brutsaert, S., Lee, G. and Schindler, C. (2000). A Stat3-interacting
protein (StIP1) regulates cytokine signal transduction. Proc Natl Acad Sci U S A 97,
10120-5.
Cooley, L., Kelley, R. and Spradling, A. (1988). Insertional mutagenesis of the
Drosophila genome with single P elements. Science 239, 1121-8.
Crozatier, M., Glise, B. and Vincent, A. (2002). Connecting Hh, Dpp and EGF
signalling in patterning of the Drosophila wing; the pivotal role of collier/knot in the AP
organiser. Development 129, 4261-9.
Davey, H. W., McLachlan, M. J., Wilkins, R. J., Hilton, D. J. and Adams, T. E.
(1999). STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in
the liver. Mol Cell Endocrinol 158, 111-6.

130

David, M., Wong, L., Flavell, R., Thompson, S. A., Wells, A., Larner, A. C. and
Johnson, G. R. (1996). STAT activation by epidermal growth factor (EGF) and
amphiregulin. Requirement for the EGF receptor kinase but not for tyrosine
phosphorylation sites or JAK1. J Biol Chem 271, 9185-8.
De Celis, J. F. (2003). Pattern formation in the Drosophila wing: The development of the
veins. Bioessays 25, 443-51.
de Celis, J. F. and Barrio, R. (2000). Function of the spalt/spalt-related gene complex in
positioning the veins in the Drosophila wing. Mech Dev 91, 31-41.
De Sepulveda, P., Ilangumaran, S. and Rottapel, R. (2000). Suppressor of cytokine
signaling-1 inhibits VAV function through protein degradation. J Biol Chem 275, 140058.
Dearolf, C. R. (1999). JAKs and STATs in invertebrate model organisms. Cell Mol Life
Sci 55, 1578-84.
Decker, T. and Kovarik, P. (2000). Serine phosphorylation of STATs. Oncogene 19,
2628-37.
Dierick, H. and Bejsovec, A. (1999). Cellular mechanisms of wingless/Wnt signal
transduction. Curr Top Dev Biol 43, 153-90.
Doll, R. F., Kaufman, P. D., Misra, S. and Rio, D. C. (1989). Molecular biology of
Drosophila P-element transposition. Prog Nucleic Acid Res Mol Biol 36, 47-57.
Eberl, D. F., Perkins, L. A., Engelstein, M., Hilliker, A. J. and Perrimon, N. (1992).
Genetic and developmental analysis of polytene section 17 of the X chromosome of
Drosophila melanogaster. Genetics 130, 569-83.
Eddy, S. R. (1998). Profile hidden Markov models. Bioinformatics 14, 755-63.
Eldar, A., Dorfman, R., Weiss, D., Ashe, H., Shilo, B. Z. and Barkai, N. (2002).
Robustness of the BMP morphogen gradient in Drosophila embryonic patterning. Nature
419, 304-8.
Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K.,
Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H. et al. (1997). A new protein
containing an SH2 domain that inhibits JAK kinases. Nature 387, 921-4.
Engels, W. R. (1989). P elements in Drosophila. In Berg, Howe, 1989, (ed., pp. 437-484.
Engels, W. R. (1997). Invasions of P elements. Genetics 145, 11-5.
Engels, W. R., Johnson-Schlitz, D. M., Eggleston, W. B. and Sved, J. (1990). Highfrequency P element loss in Drosophila is homolog dependent. Cell 62, 515-25.

131

Evans, C. J., Hartenstein, V. and Banerjee, U. (2003). Thicker than blood: conserved
mechanisms in Drosophila and vertebrate hematopoiesis. Dev Cell 5, 673-90.
Favre, H., Benhamou, A., Finidori, J., Kelly, P. A. and Edery, M. (1999). Dual effects
of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction.
FEBS Lett 453, 63-6.
FlyBase Consortium. (2003). The FlyBase database of the Drosophila genome projects
and community literature. Nucleic Acids Res 31, 172-5.
Foster, F. M., Traer, C. J., Abraham, S. M. and Fry, M. J. (2003). The
phosphoinositide (PI) 3-kinase family. J Cell Sci 116, 3037-40.
Fujimoto, M. and Naka, T. (2003). Regulation of cytokine signaling by SOCS family
molecules. Trends Immunol 24, 659-66.
Furukawa, M., He, Y. J., Borchers, C. and Xiong, Y. (2003). Targeting of protein
ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases. Nat Cell Biol 5, 1001-7.
Furukawa, M., Ohta, T. and Xiong, Y. (2002). Activation of UBC5 ubiquitinconjugating enzyme by the RING finger of ROC1 and assembly of active ubiquitin
ligases by all cullins. J Biol Chem 277, 15758-65.
Garcia-Bellido, A., Cortes, F. and Milan, M. (1994). Cell interactions in the control of
size in Drosophila wings. Proc Natl Acad Sci U S A 91, 10222-6.
Geer, L. Y., Domrachev, M., Lipman, D. J. and Bryant, S. H. (2002). CDART:
protein homology by domain architecture. Genome Res 12, 1619-23.
Giordano, V., De Falco, G., Chiari, R., Quinto, I., Pelicci, P. G., Bartholomew, L.,
Delmastro, P., Gadina, M. and Scala, G. (1997). Shc mediates IL-6 signaling by
interacting with gp130 and Jak2 kinase. J Immunol 158, 4097-103.
Gloor, G. B., Moretti, J., Mouyal, J. and Keeler, K. J. (2000). Distinct P-element
excision products in somatic and germline cells of Drosophila melanogaster. Genetics
155, 1821-30.
Gloor, G. B., Nassif, N. A., Johnson-Schlitz, D. M., Preston, C. R. and Engels, W. R.
(1991). Targeted gene replacement in Drosophila via P element-induced gap repair.
Science 253, 1110-7.
Gonzalez-Reyes, A., Elliott, H. and St Johnston, D. (1995). Polarization of both major
body axes in Drosophila by gurken-torpedo signalling. Nature 375, 654-8.
Gonzalez-Reyes, A. and St Johnston, D. (1998). Patterning of the follicle cell
epithelium along the anterior-posterior axis during Drosophila oogenesis. Development
125, 2837-46.

132

Gouilleux-Gruart, V., Gouilleux, F., Desaint, C., Claisse, J. F., Capiod, J. C.,
Delobel, J., Weber-Nordt, R., Dusanter-Fourt, I., Dreyfus, F., Groner, B. et al.
(1996). STAT-related transcription factors are constitutively activated in peripheral blood
cells from acute leukemia patients. Blood 87, 1692-7.
Graves, J. D. and Krebs, E. G. (1999). Protein phosphorylation and signal transduction.
Pharmacol Ther 82, 111-21.
Greenspan, R. J. (1997). Fly pushing: the theory and practice of Drosophila genetics.
Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY.
Gresser, I., Aguet, M., Morel-Maroger, L., Woodrow, D., Puvion-Dutilleul, F.,
Guillon, J. C. and Maury, C. (1981). Electrophoretically pure mouse interferon inhibits
growth, induces liver and kidney lesions, and kills suckling mice. Am J Pathol 102, 396402.
Guichard, A., Biehs, B., Sturtevant, M. A., Wickline, L., Chacko, J., Howard, K. and
Bier, E. (1999). rhomboid and Star interact synergistically to promote EGFR/MAPK
signaling during Drosophila wing vein development. Development 126, 2663-76.
Haan, S., Ferguson, P., Sommer, U., Hiremath, M., McVicar, D. W., Heinrich, P. C.,
Johnston, J. A. and Cacalano, N. A. (2003). Tyrosine phosphorylation disrupts elongin
interaction and accelerates SOCS3 degradation. J Biol Chem 278, 31972-9.
Hafen, E., Dickson, B., Brunner, D. and Raabe, T. (1994). Genetic dissection of signal
transduction mediated by the sevenless receptor tyrosine kinase in Drosophila. Prog
Neurobiol 42, 287-92.
Handler, A. M. (2001). A current perspective on insect gene transformation. Insect
Biochem Mol Biol 31, 111-28.
Handler, A. M. and Harrell, R. A., 2nd. (1999). Germline transformation of Drosophila
melanogaster with the piggyBac transposon vector. Insect Mol Biol 8, 449-57.
Hanratty, W. P. and Dearolf, C. R. (1993). The Drosophila Tumorous-lethal
hematopoietic oncogene is a dominant mutation in the hopscotch locus. Mol Gen Genet
238, 33-7.
Hansen, J. A., Lindberg, K., Hilton, D. J., Nielsen, J. H. and Billestrup, N. (1999).
Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine
signaling proteins. Mol Endocrinol 13, 1832-43.
Hari, K. L., Cook, K. R. and Karpen, G. H. (2001). The Drosophila Su(var)2-10 locus
regulates chromosome structure and function and encodes a member of the PIAS protein
family. Genes Dev 15, 1334-48.

133

Harrison, D. A., Binari, R., Nahreini, T. S., Gilman, M. and Perrimon, N. (1995).
Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and
developmental defects. Embo J 14, 2857-65.
Harrison, D. A., McCoon, P. E., Binari, R., Gilman, M. and Perrimon, N. (1998).
Drosophila unpaired encodes a secreted protein that activates the JAK signaling pathway.
Genes Dev 12, 3252-63.
Heinrich, P. C., Behrmann, I., Haan, S., Hermanns, H. M., Muller-Newen, G. and
Schaper, F. (2003). Principles of interleukin (IL)-6-type cytokine signalling and its
regulation. Biochem J 374, 1-20.
Hilton, D. J., Richardson, R. T., Alexander, W. S., Viney, E. M., Willson, T. A.,
Sprigg, N. S., Starr, R., Nicholson, S. E., Metcalf, D. and Nicola, N. A. (1998).
Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc
Natl Acad Sci U S A 95, 114-9.
Ho, J. M., Beattie, B. K., Squire, J. A., Frank, D. A. and Barber, D. L. (1999). Fusion
of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling. Blood
93, 4354-64.
Hombria, J. C. and Brown, S. (2002). The fertile field of Drosophila Jak/STAT
signalling. Curr Biol 12, R569-75.
Hou, X. S., Melnick, M. B. and Perrimon, N. (1996). Marelle acts downstream of the
Drosophila HOP/JAK kinase and encodes a protein similar to the mammalian STATs.
Cell 84, 411-9.
Igaz, P., Toth, S. and Falus, A. (2001). Biological and clinical significance of the JAKSTAT pathway; lessons from knockout mice. Inflamm Res 50, 435-41.
Imada, K. and Leonard, W. J. (2000). The Jak-STAT pathway. Mol Immunol 37, 1-11.
Isaac, D. D. and Andrew, D. J. (1996). Tubulogenesis in Drosophila: a requirement for
the trachealess gene product. Genes Dev 10, 103-17.
Ito, K., Awano, W., Suzuki, K., Hiromi, Y. and Yamamoto, D. (1997). The
Drosophila mushroom body is a quadruple structure of clonal units each of which
contains a virtually identical set of neurones and glial cells. Development 124, 761-71.
Ivashkiv, L. B. and Hu, X. (2003). The JAK/STAT pathway in rheumatoid arthritis:
pathogenic or protective? Arthritis Rheum 48, 2092-6.
Iwamoto, T., Oshima, K., Seng, T., Feng, X., Oo, M. L., Hamaguchi, M. and
Matsuda, S. (2002). STAT and SMAD signaling in cancer. Histol Histopathol 17, 88795.

134

Jiao, H., Berrada, K., Yang, W., Tabrizi, M., Platanias, L. C. and Yi, T. (1996).
Direct association with and dephosphorylation of Jak2 kinase by the SH2-domaincontaining protein tyrosine phosphatase SHP-1. Mol Cell Biol 16, 6985-92.
Jinks, T. M., Polydorides, A. D., Calhoun, G. and Schedl, P. (2000). The JAK/STAT
signaling pathway is required for the initial choice of sexual identity in Drosophila
melanogaster. Mol Cell 5, 581-7.
Johnson-Schlitz, D. M. and Engels, W. R. (1993). P-element-induced interallelic gene
conversion of insertions and deletions in Drosophila melanogaster. Mol Cell Biol 13,
7006-18.
Johnston, J. A. and O'Shea, J. J. (2003). Matching SOCS with function. Nat Immunol
4, 507-9.
Kamura, T., Sato, S., Haque, D., Liu, L., Kaelin, W. G., Jr., Conaway, R. C. and
Conaway, J. W. (1998). The Elongin BC complex interacts with the conserved SOCSbox motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat
families. Genes Dev 12, 3872-81.
Karsten, P., Hader, S. and Zeidler, M. P. (2002). Cloning and expression of Drosophila
SOCS36E and its potential regulation by the JAK/STAT pathway. Mech Dev 117, 343-6.
Kaufman, P. D., Doll, R. F. and Rio, D. C. (1989). Drosophila P element transposase
recognizes internal P element DNA sequences. Cell 59, 359-71.
Kaufman, P. D. and Rio, D. C. (1992). P element transposition in vitro proceeds by a
cut-and-paste mechanism and uses GTP as a cofactor. Cell 69, 27-39.
Kawata, T., Shevchenko, A., Fukuzawa, M., Jermyn, K. A., Totty, N. F.,
Zhukovskaya, N. V., Sterling, A. E., Mann, M. and Williams, J. G. (1997). SH2
signaling in a lower eukaryote: a STAT protein that regulates stalk cell differentiation in
dictyostelium. Cell 89, 909-16.
Kelley, M. R., Kidd, S., Berg, R. L. and Young, M. W. (1987). Restriction of Pelement insertions at the Notch locus of Drosophila melanogaster. Mol Cell Biol 7, 15458.
Kiger, A. A., Jones, D. L., Schulz, C., Rogers, M. B. and Fuller, M. T. (2001). Stem
cell self-renewal specified by JAK-STAT activation in response to a support cell cue.
Science 294, 2542-5.
Krebs, D. L., Uren, R. T., Metcalf, D., Rakar, S., Zhang, J. G., Starr, R., De Souza,
D. P., Hanzinikolas, K., Eyles, J., Connolly, L. M. et al. (2002). SOCS-6 binds to
insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth
retardation. Mol Cell Biol 22, 4567-78.

135

Kubo, M., Hanada, T. and Yoshimura, A. (2003). Suppressors of cytokine signaling
and immunity. Nat Immunol 4, 1169-76.
Lacronique, V., Boureux, A., Valle, V. D., Poirel, H., Quang, C. T., Mauchauffe, M.,
Berthou, C., Lessard, M., Berger, R., Ghysdael, J. et al. (1997). A TEL-JAK2 fusion
protein with constitutive kinase activity in human leukemia. Science 278, 1309-12.
Lanot, R., Zachary, D., Holder, F. and Meister, M. (2001). Postembryonic
hematopoiesis in Drosophila. Dev Biol 230, 243-57.
Leaman, D. W., Pisharody, S., Flickinger, T. W., Commane, M. A., Schlessinger, J.,
Kerr, I. M., Levy, D. E. and Stark, G. R. (1996). Roles of JAKs in activation of STATs
and stimulation of c-fos gene expression by epidermal growth factor. Mol Cell Biol 16,
369-75.
Lebestky, T., Chang, T., Hartenstein, V. and Banerjee, U. (2000). Specification of
Drosophila hematopoietic lineage by conserved transcription factors. Science 288, 146-9.
Leonard, W. J. (1996). Dysfunctional cytokine receptor signaling in severe combined
immunodeficiency. J Investig Med 44, 304-11.
Letunic, I., Copley, R. R., Schmidt, S., Ciccarelli, F. D., Doerks, T., Schultz, J.,
Ponting, C. P. and Bork, P. (2004). SMART 4.0: towards genomic data integration.
Nucleic Acids Res 32 Database issue, D142-4.
Lewis, E. B. and Bacher, F. (1968). Methods of feeding ethyl methane sulfonate (EMS)
to Drosophila males. D. I. S. 43, 193.
Lewis, S. E., Searle, S. M., Harris, N., Gibson, M., Lyer, V., Richter, J., Wiel, C.,
Bayraktaroglir, L., Birney, E., Crosby, M. A. et al. (2002). Apollo: a sequence
annotation editor. Genome Biol 3, RESEARCH0082.
Liu, B., Liao, J., Rao, X., Kushner, S. A., Chung, C. D., Chang, D. D. and Shuai, K.
(1998). Inhibition of Stat1-mediated gene activation by PIAS1. Proc Natl Acad Sci U S A
95, 10626-31.
Liu, E., Cote, J. F. and Vuori, K. (2003). Negative regulation of FAK signaling by
SOCS proteins. Embo J 22, 5036-46.
Luo, H., Asha, H., Kockel, L., Parke, T., Mlodzik, M. and Dearolf, C. R. (1999). The
Drosophila Jak kinase hopscotch is required for multiple developmental processes in the
eye. Dev Biol 213, 432-41.
Luo, H. and Dearolf, C. R. (2001). The JAK/STAT pathway and Drosophila
development. Bioessays 23, 1138-47.

136

Luo, H., Hanratty, W. P. and Dearolf, C. R. (1995). An amino acid substitution in the
Drosophila hopTum-l Jak kinase causes leukemia-like hematopoietic defects. Embo J 14,
1412-20.
Luo, H., Rose, P., Barber, D., Hanratty, W. P., Lee, S., Roberts, T. M., D'Andrea, A.
D. and Dearolf, C. R. (1997). Mutation in the Jak kinase JH2 domain hyperactivates
Drosophila and mammalian Jak-Stat pathways. Mol Cell Biol 17, 1562-71.
Luo, H., Rose, P. E., Roberts, T. M. and Dearolf, C. R. (2002). The Hopscotch Jak
kinase requires the Raf pathway to promote blood cell activation and differentiation in
Drosophila. Mol Genet Genomics 267, 57-63.
Manning, G. and Krasnow, M. A. (1993). Development of the Drosophila tracheal
system. In Bate, Martinez Arias, 1993, (ed., pp. 609--685.
Marchler-Bauer, A., Anderson, J. B., DeWeese-Scott, C., Fedorova, N. D., Geer, L.
Y., He, S., Hurwitz, D. I., Jackson, J. D., Jacobs, A. R., Lanczycki, C. J. et al. (2003).
CDD: a curated Entrez database of conserved domain alignments. Nucleic Acids Res 31,
383-7.
Marcus, J. M. (2001). The development and evolution of crossveins in insect wings. J
Anat 199, 211-6.
Marine, J. C., McKay, C., Wang, D., Topham, D. J., Parganas, E., Nakajima, H.,
Pendeville, H., Yasukawa, H., Sasaki, A., Yoshimura, A. et al. (1999a). SOCS3 is
essential in the regulation of fetal liver erythropoiesis. Cell 98, 617-27.
Marine, J. C., Topham, D. J., McKay, C., Wang, D., Parganas, E., Stravopodis, D.,
Yoshimura, A. and Ihle, J. N. (1999b). SOCS1 deficiency causes a lymphocytedependent perinatal lethality. Cell 98, 609-16.
Matsumoto, A., Seki, Y., Kubo, M., Ohtsuka, S., Suzuki, A., Hayashi, I., Tsuji, K.,
Nakahata, T., Okabe, M., Yamada, S. et al. (1999). Suppression of STAT5 functions in
liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1
transgenic mice. Mol Cell Biol 19, 6396-407.
McGregor, J. R., Xi, R. and Harrison, D. A. (2002). JAK signaling is somatically
required for follicle cell differentiation in Drosophila. Development 129, 705-17.
Metcalf, D., Alexander, W. S., Elefanty, A. G., Nicola, N. A., Hilton, D. J., Starr, R.,
Mifsud, S. and Di Rago, L. (1999). Aberrant hematopoiesis in mice with inactivation of
the gene encoding SOCS-1. Leukemia 13, 926-34.
Metcalf, D., Greenhalgh, C. J., Viney, E., Willson, T. A., Starr, R., Nicola, N. A.,
Hilton, D. J. and Alexander, W. S. (2000). Gigantism in mice lacking suppressor of
cytokine signalling-2. Nature 405, 1069-73.

137

Methot, N. and Basler, K. (1999). Hedgehog controls limb development by regulating
the activities of distinct transcriptional activator and repressor forms of Cubitus
interruptus. Cell 96, 819-31.
Metzger, R. J. and Krasnow, M. A. (1999). Genetic control of branching
morphogenesis. Science 284, 1635-9.
Miklos, G. L. and Rubin, G. M. (1996). The role of the genome project in determining
gene function: insights from model organisms. Cell 86, 521-9.
Mohr, S. E. and Boswell, R. E. (1999). Zimp encodes a homologue of mouse Miz1 and
PIAS3 and is an essential gene in Drosophila melanogaster. Gene 229, 109-16.
Mohr, S. E. and Gelbart, W. M. (2002). Using the P[wHy] hybrid transposable element
to disrupt genes in region 54D-55B in Drosophila melanogaster. Genetics 162, 165-76.
Mooney, R. A., Senn, J., Cameron, S., Inamdar, N., Boivin, L. M., Shang, Y. and
Furlanetto, R. W. (2001). Suppressors of cytokine signaling-1 and -6 associate with and
inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin
resistance. J Biol Chem 276, 25889-93.
Morimoto, A. M., Jordan, K. C., Tietze, K., Britton, J. S., O'Neill, E. M. and
Ruohola-Baker, H. (1996). Pointed, an ETS domain transcription factor, negatively
regulates the EGF receptor pathway in Drosophila oogenesis. Development 122, 3745-54.
Moustakas, A. (2002). Smad signalling network. J Cell Sci 115, 3355-6.
Mullor, J. L., Calleja, M., Capdevila, J. and Guerrero, I. (1997). Hedgehog activity,
independent of decapentaplegic, participates in wing disc patterning. Development 124,
1227-37.
Naka, T. and Kishimoto, T. (2002). Joint disease caused by defective gp130-mediated
STAT signaling. Arthritis Res 4, 154-6.
Naka, T., Matsumoto, T., Narazaki, M., Fujimoto, M., Morita, Y., Ohsawa, Y.,
Saito, H., Nagasawa, T., Uchiyama, Y. and Kishimoto, T. (1998). Accelerated
apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT
inhibitor-1) deficient mice. Proc Natl Acad Sci U S A 95, 15577-82.
Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A.,
Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K. et al. (1997). Structure and function
of a new STAT-induced STAT inhibitor. Nature 387, 924-9.
Naka, T., Nishimoto, N. and Kishimoto, T. (2002). The paradigm of IL-6: from basic
science to medicine. Arthritis Res 4 Suppl 3, S233-42.

138

Narazaki, M., Fujimoto, M., Matsumoto, T., Morita, Y., Saito, H., Kajita, T.,
Yoshizaki, K., Naka, T. and Kishimoto, T. (1998). Three distinct domains of SSI1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling. Proc
Natl Acad Sci U S A 95, 13130-4.
Nassif, N. and Engels, W. (1993). DNA homology requirements for mitotic gap repair in
Drosophila. Proc Natl Acad Sci U S A 90, 1262-6.
Neubauer, H., Cumano, A., Muller, M., Wu, H., Huffstadt, U. and Pfeffer, K. (1998).
Jak2 deficiency defines an essential developmental checkpoint in definitive
hematopoiesis. Cell 93, 397-409.
Neufeld, T. P., de la Cruz, A. F., Johnston, L. A. and Edgar, B. A. (1998).
Coordination of growth and cell division in the Drosophila wing. Cell 93, 1183-93.
Nicholson, S. E., De Souza, D., Fabri, L. J., Corbin, J., Willson, T. A., Zhang, J. G.,
Silva, A., Asimakis, M., Farley, A., Nash, A. D. et al. (2000). Suppressor of cytokine
signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor
subunit gp130. Proc Natl Acad Sci U S A 97, 6493-8.
Nicholson, S. E., Willson, T. A., Farley, A., Starr, R., Zhang, J. G., Baca, M.,
Alexander, W. S., Metcalf, D., Hilton, D. J. and Nicola, N. A. (1999). Mutational
analyses of the SOCS proteins suggest a dual domain requirement but distinct
mechanisms for inhibition of LIF and IL-6 signal transduction. Embo J 18, 375-85.
Nilson, L. A. and Schupbach, T. (1999). EGF receptor signaling in Drosophila
oogenesis. Curr Top Dev Biol 44, 203-43.
Nusslein-Volhard, C. (1979). Maternal effect mutations that affect the spatial
coordinates of the embryo of Drosophila melanogaster. In Subtelny, Konigsberg, 1979,
(ed., pp. 185--211.
Nusslein-Volhard, C., Frohnhofer, H. G. and Lehmann, R. (1987). Determination of
anteroposterior polarity in Drosophila. Science 238, 1675-81.
Nusslein-Volhard, C. and Wieschaus, E. (1980). Mutations affecting segment number
and polarity in Drosophila. Nature 287, 795-801.
Nusslein-Volhard, C., Wieschaus, E. and Kluding, H. (1984). Mutations affecting the
pattern of the larval cuticle in Drosophila melanogaster. I. Zygotic loci on the second
chromosome. 193, 267--282.
O'Brien, K. B., O'Shea, J. J. and Carter-Su, C. (2002). SH2-B family members
differentially regulate JAK family tyrosine kinases. J Biol Chem 277, 8673-81.
O'Brochta, D. A., Gomez, S. P. and Handler, A. M. (1991). P element excision in
Drosophila melanogaster and related drosophilids. Mol Gen Genet 225, 387-94.

139

Oh, S. W., Kingsley, T., Shin, H. H., Zheng, Z., Chen, H. W., Chen, X., Wang, H.,
Ruan, P., Moody, M. and Hou, S. X. (2003). A P-element insertion screen identified
mutations in 455 novel essential genes in Drosophila. Genetics 163, 195-201.
O'Hare, K. and Rubin, G. M. (1983). Structures of P transposable elements and their
sites of insertion and excision in the Drosophila melanogaster genome. Cell 34, 25-35.
Olivier, J. P., Raabe, T., Henkemeyer, M., Dickson, B., Mbamalu, G., Margolis, B.,
Schlessinger, J., Hafen, E. and Pawson, T. (1993). A Drosophila SH2-SH3 adaptor
protein implicated in coupling the sevenless tyrosine kinase to an activator of Ras
guanine nucleotide exchange, Sos. Cell 73, 179-91.
O'Shea, J. J., Gadina, M. and Schreiber, R. D. (2002). Cytokine signaling in 2002:
new surprises in the Jak/Stat pathway. Cell 109 Suppl, S121-31.
Parganas, E., Wang, D., Stravopodis, D., Topham, D. J., Marine, J. C., Teglund, S.,
Vanin, E. F., Bodner, S., Colamonici, O. R., van Deursen, J. M. et al. (1998). Jak2 is
essential for signaling through a variety of cytokine receptors. Cell 93, 385-95.
Parks, A. L., Cook, K. R., Belvin, M., Dompe, N. A., Fawcett, R., Huppert, K., Tan,
L. R., Winter, C. G., Bogart, K. P., Deal, J. E. et al. (2004). Systematic generation of
high-resolution deletion coverage of the Drosophila melanogaster genome. Nat Genet 36,
288-92.
Pastink, A., Heemskerk, E., Nivard, M. J., van Vliet, C. J. and Vogel, E. W. (1991).
Mutational specificity of ethyl methanesulfonate in excision-repair-proficient and deficient strains of Drosophila melanogaster. Mol Gen Genet 229, 213-8.
Patel, N. H. (1994). Imaging neuronal subsets and other cell types in whole-mount
Drosophila embryos and larvae using antibody probes. Methods Cell Biol 44, 445-87.
Peeters, P., Raynaud, S. D., Cools, J., Wlodarska, I., Grosgeorge, J., Philip, P.,
Monpoux, F., Van Rompaey, L., Baens, M., Van den Berghe, H. et al. (1997). Fusion
of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a
result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood 90, 2535-40.
Peltola, K. J., Paukku, K., Aho, T. L., Ruuska, M., Silvennoinen, O. and Koskinen,
P. J. (2004). Pim-1 kinase inhibits STAT5-dependent transcription via its interactions
with SOCS1 and SOCS3. Blood 103, 3744-50.
Perrimon, N., Engstrom, L. and Mahowald, A. P. (1989). Zygotic lethals with specific
maternal effect phenotypes in Drosophila melanogaster. I. Loci on the X chromosome.
Genetics 121, 333-52.
Perrimon, N. and Mahowald, A. P. (1986). l(1)hopscotch, A larval-pupal zygotic lethal
with a specific maternal effect on segmentation in Drosophila. Dev Biol 118, 28-41.

140

Preston, C. R., Sved, J. A. and Engels, W. R. (1996). Flanking duplications and
deletions associated with P-induced male recombination in Drosophila. Genetics 144,
1623-38.
Qu, C. K. (2002). Role of the SHP-2 tyrosine phosphatase in cytokine-induced signaling
and cellular response. Biochim Biophys Acta 1592, 297-301.
Ram, P. A. and Waxman, D. J. (2000). Role of the cytokine-inducible SH2 protein CIS
in desensitization of STAT5b signaling by continuous growth hormone. J Biol Chem 275,
39487-96.
Rane, S. G. and Reddy, E. P. (2000). Janus kinases: components of multiple signaling
pathways. Oncogene 19, 5662-79.
Rawlings, J. S., Rosler, K. M. and Harrison, D. A. (2004). The JAK/STAT signaling
pathway. J Cell Sci 117, 1281-3.
Rio, D. C. and Rubin, G. M. (1988). Identification and purification of a Drosophila
protein that binds to the terminal 31-base-pair inverted repeats of the P transposable
element. Proc Natl Acad Sci U S A 85, 8929-33.
Robertson, H. M., Preston, C. R., Phillis, R. W., Johnson-Schlitz, D. M., Benz, W. K.
and Engels, W. R. (1988). A stable genomic source of P element transposase in
Drosophila melanogaster. Genetics 118, 461-70.
Rong, Y. S. and Golic, K. G. (2001). A targeted gene knockout in drosophila. Genetics
157, 1307-12.
Rong, Y. S., Titen, S. W., Xie, H. B., Golic, M. M., Bastiani, M., Bandyopadhyay, P.,
Olivera, B. M., Brodsky, M., Rubin, G. M. and Golic, K. G. (2002). Targeted
mutagenesis by homologous recombination in D. melanogaster. Genes Dev 16, 1568-81.
Rorth, P. (1998). Gal4 in the Drosophila female germline. Mech Dev 78, 113-8.
Roseman, R. R., Johnson, E. A., Rodesch, C. K., Bjerke, M., Nagoshi, R. N. and
Geyer, P. K. (1995). A P element containing suppressor of hairy-wing binding regions
has novel properties for mutagenesis in Drosophila melanogaster. Genetics 141, 1061-74.
Roth, S., Neuman-Silberberg, F. S., Barcelo, G. and Schupbach, T. (1995). cornichon
and the EGF receptor signaling process are necessary for both anterior-posterior and
dorsal-ventral pattern formation in Drosophila. Cell 81, 967-78.
Rottapel, R. (2001). Putting the brakes on arthritis: can suppressors of cytokine signaling
(SOCS) suppress rheumatoid arthritis? J Clin Invest 108, 1745-7.

141

Sakamoto, H., Yasukawa, H., Masuhara, M., Tanimura, S., Sasaki, A., Yuge, K.,
Ohtsubo, M., Ohtsuka, A., Fujita, T., Ohta, T. et al. (1998). A Janus kinase inhibitor,
JAB, is an interferon-gamma-inducible gene and confers resistance to interferons. Blood
92, 1668-76.
Sanger, F., Nicklen, S. and Coulson, A. R. (1977). DNA sequencing with chainterminating inhibitors. Proc Natl Acad Sci U S A 74, 5463-7.
Sawamoto, K., Okabe, M., Tanimura, T., Mikoshiba, K., Nishida, Y. and Okano, H.
(1996). The Drosophila secreted protein Argos regulates signal transduction in the
Ras/MAPK pathway. Dev Biol 178, 13-22.
Sawamoto, K., Okano, H., Kobayakawa, Y., Hayashi, S., Mikoshiba, K. and
Tanimura, T. (1994). The function of argos in regulating cell fate decisions during
Drosophila eye and wing vein development. Dev Biol 164, 267-76.
Schindler, C. (1999). Cytokines and JAK-STAT signaling. Exp Cell Res 253, 7-14.
Schnepp, B., Grumbling, G., Donaldson, T. and Simcox, A. (1996). Vein is a novel
component in the Drosophila epidermal growth factor receptor pathway with similarity to
the neuregulins. Genes Dev 10, 2302-13.
Schultz, J., Copley, R. R., Doerks, T., Ponting, C. P. and Bork, P. (2000). SMART: a
web-based tool for the study of genetically mobile domains. Nucleic Acids Res 28, 231-4.
Schultz, J., Milpetz, F., Bork, P. and Ponting, C. P. (1998). SMART, a simple modular
architecture research tool: identification of signaling domains. Proc Natl Acad Sci U S A
95, 5857-64.
Schupbach, T. and Wieschaus, E. (1986). Maternal-effect mutations altering the
anterior-posterior pattern of the Drosophila embryo. III. Zygotic loci on the Xchromosome and fourth chromosome. 195, 302--317.
Schupbach, T. and Wieschaus, E. (1989). Female sterile mutations on the second
chromosome of Drosophila melanogaster. I. Maternal effect mutations. Genetics 121,
101-17.
Schupbach, T. and Wieschaus, E. (1991). Female sterile mutations on the second
chromosome of Drosophila melanogaster. II. Mutations blocking oogenesis or altering
egg morphology. Genetics 129, 1119-36.
Schweisguth, F. (2004). Notch signaling activity. Curr Biol 14, R129-38.
Schweitzer, R., Howes, R., Smith, R., Shilo, B. Z. and Freeman, M. (1995). Inhibition
of Drosophila EGF receptor activation by the secreted protein Argos. Nature 376, 699702.

142

Seki, Y., Hayashi, K., Matsumoto, A., Seki, N., Tsukada, J., Ransom, J., Naka, T.,
Kishimoto, T., Yoshimura, A. and Kubo, M. (2002). Expression of the suppressor of
cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and
Th2 differentiation. Proc Natl Acad Sci U S A 99, 13003-8.
Sentry, J. W. and Kaiser, K. (1992). P element transposition and targeted manipulation
of the Drosophila genome. Trends Genet 8, 329-31.
Shi, Y. and Massague, J. (2003). Mechanisms of TGF-beta signaling from cell
membrane to the nucleus. Cell 113, 685-700.
Shilo, B. Z., Gabay, L., Glazer, L., Reichman-Fried, M., Wappner, P., Wilk, R. and
Zelzer, E. (1997). Branching morphogenesis in the Drosophila tracheal system. Cold
Spring Harb Symp Quant Biol 62, 241-7.
Shouda, T., Yoshida, T., Hanada, T., Wakioka, T., Oishi, M., Miyoshi, K., Komiya,
S., Kosai, K., Hanakawa, Y., Hashimoto, K. et al. (2001). Induction of the cytokine
signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis.
J Clin Invest 108, 1781-8.
Shuai, K. (2000). Modulation of STAT signaling by STAT-interacting proteins.
Oncogene 19, 2638-44.
Silver, D. L. and Montell, D. J. (2001). Paracrine signaling through the JAK/STAT
pathway activates invasive behavior of ovarian epithelial cells in Drosophila. Cell 107,
831-41.
Small, S., Blair, A. and Levine, M. (1996). Regulation of two pair-rule stripes by a
single enhancer in the Drosophila embryo. Dev Biol 175, 314-24.
Spradling, A. C. (1986). P element-mediated transformation. In Roberts, 1986, (ed., pp.
175--198.
Spradling, A. C., Stern, D., Beaton, A., Rhem, E. J., Laverty, T., Mozden, N., Misra,
S. and Rubin, G. M. (1999). The Berkeley Drosophila Genome Project gene disruption
project: Single P-element insertions mutating 25% of vital Drosophila genes. Genetics
153, 135-77.
Starr, R., Metcalf, D., Elefanty, A. G., Brysha, M., Willson, T. A., Nicola, N. A.,
Hilton, D. J. and Alexander, W. S. (1998). Liver degeneration and lymphoid
deficiencies in mice lacking suppressor of cytokine signaling-1. Proc Natl Acad Sci U S
A 95, 14395-9.
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J., Rayner, J. R., Jenkins, B. J.,
Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A. et al. (1997). A family of
cytokine-inducible inhibitors of signalling. Nature 387, 917-21.

143

Struhl, G. and Basler, K. (1993). Organizing activity of wingless protein in Drosophila.
Cell 72, 527-40.
Sturtevant, M. A., Roark, M. and Bier, E. (1993). The Drosophila rhomboid gene
mediates the localized formation of wing veins and interacts genetically with components
of the EGF-R signaling pathway. Genes Dev 7, 961-73.
Taguchi, A., Sawamoto, K. and Okano, H. (2000). Mutations Modulating the ArgosRegulated Signaling Pathway in Drosophila Eye Development. Genetics 154, 1639-1648.
Takaoka, A., Tanaka, N., Mitani, Y., Miyazaki, T., Fujii, H., Sato, M., Kovarik, P.,
Decker, T., Schlessinger, J. and Taniguchi, T. (1999). Protein tyrosine kinase Pyk2
mediates the Jak-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFNalpha, signaling. Embo J 18, 2480-8.
Thibault, S. T., Singer, M. A., Miyazaki, W. Y., Milash, B., Dompe, N. A., Singh, C.
M., Buchholz, R., Demsky, M., Fawcett, R., Francis-Lang, H. L. et al. (2004). A
complementary transposon tool kit for Drosophila melanogaster using P and piggyBac.
Nat Genet 36, 283-7.
Timakov, B., Liu, X., Turgut, I. and Zhang, P. (2002). Timing and targeting of Pelement local transposition in the male germline cells of Drosophila melanogaster.
Genetics 160, 1011-22.
Torok, T., Tick, G., Alvarado, M. and Kiss, I. (1993). P-lacW insertional mutagenesis
on the second chromosome of Drosophila melanogaster: isolation of lethals with different
overgrowth phenotypes. Genetics 135, 71--80.
Tower, J., Karpen, G. H., Craig, N. and Spradling, A. C. (1993). Preferential
transposition of Drosophila P elements to nearby chromosomal sites. Genetics 133, 34759.
Tracey, W. D., Jr., Ning, X., Klingler, M., Kramer, S. G. and Gergen, J. P. (2000).
Quantitative analysis of gene function in the Drosophila embryo. Genetics 154, 273-84.
Tulina, N. and Matunis, E. (2001). Control of stem cell self-renewal in Drosophila
spermatogenesis by JAK-STAT signaling. Science 294, 2546-9.
Verdier, F., Chretien, S., Muller, O., Varlet, P., Yoshimura, A., Gisselbrecht, S.,
Lacombe, C. and Mayeux, P. (1998). Proteasomes regulate erythropoietin receptor and
signal transducer and activator of transcription 5 (STAT5) activation. Possible
involvement of the ubiquitinated Cis protein. J Biol Chem 273, 28185-90.
Ward, A. C., Touw, I. and Yoshimura, A. (2000). The Jak-Stat pathway in normal and
perturbed hematopoiesis. Blood 95, 19-29.
Wes, P. D., Yu, M. and Montell, C. (1996). RIC, a calmodulin-binding Ras-like
GTPase. Embo J 15, 5839-48.
144

Wilkie, G. S., Shermoen, A. W., O'Farrell, P. H. and Davis, I. (1999). Transcribed
genes are localized according to chromosomal position within polarized Drosophila
embryonic nuclei. Curr Biol 9, 1263-6.
Williams, J. A., Paddock, S. W. and Carroll, S. B. (1993). Pattern formation in a
secondary field: a hierarchy of regulatory genes subdivides the developing Drosophila
wing disc into discrete subregions. Development 117, 571-84.
Wormald, S. and Hilton, D. J. (2004). Inhibitors of cytokine signal transduction. J Biol
Chem 279, 821-4.
Xi, R., McGregor, J. R. and Harrison, D. A. (2003). A gradient of JAK pathway
activity patterns the anterior-posterior axis of the follicular epithelium. Dev Cell 4, 16777.
Yaffe, M. B. (2002). Phosphotyrosine-binding domains in signal transduction. Nat Rev
Mol Cell Biol 3, 177-86.
Yamauchi, T., Ueki, K., Tobe, K., Tamemoto, H., Sekine, N., Wada, M., Honjo, M.,
Takahashi, M., Takahashi, T., Hirai, H. et al. (1998). Growth hormone-induced
tyrosine phosphorylation of EGF receptor as an essential element leading to MAP kinase
activation and gene expression. Endocr J 45 Suppl, S27-31.
Yamauchi, T., Ueki, K., Tobe, K., Tamemoto, H., Sekine, N., Wada, M., Honjo, M.,
Takahashi, M., Takahashi, T., Hirai, H. et al. (1997). Tyrosine phosphorylation of the
EGF receptor by the kinase Jak2 is induced by growth hormone. Nature 390, 91-6.
Yan, R., Luo, H., Darnell, J. E., Jr. and Dearolf, C. R. (1996a). A JAK-STAT pathway
regulates wing vein formation in Drosophila. Proc Natl Acad Sci U S A 93, 5842-7.
Yan, R., Small, S., Desplan, C., Dearolf, C. R. and Darnell, J. E., Jr. (1996b).
Identification of a Stat gene that functions in Drosophila development. Cell 84, 421-30.
Yasukawa, H., Misawa, H., Sakamoto, H., Masuhara, M., Sasaki, A., Wakioka, T.,
Ohtsuka, S., Imaizumi, T., Matsuda, T., Ihle, J. N. et al. (1999). The JAK-binding
protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop.
Embo J 18, 1309-20.
Yeh, T. C. and Pellegrini, S. (1999). The Janus kinase family of protein tyrosine kinases
and their role in signaling. Cell Mol Life Sci 55, 1523-34.
Yoshimura, A., Ohkubo, T., Kiguchi, T., Jenkins, N. A., Gilbert, D. J., Copeland, N.
G., Hara, T. and Miyajima, A. (1995). A novel cytokine-inducible gene CIS encodes an
SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and
erythropoietin receptors. Embo J 14, 2816-26.

145

Zecca, M., Basler, K. and Struhl, G. (1995). Sequential organizing activities of
engrailed, hedgehog and decapentaplegic in the Drosophila wing. Development 121,
2265-78.
Zeidler, M. P., Bach, E. A. and Perrimon, N. (2000). The roles of the Drosophila
JAK/STAT pathway. Oncogene 19, 2598-606.
Zeidler, M. P., Perrimon, N. and Strutt, D. I. (1999). Polarity determination in the
Drosophila eye: a novel role for unpaired and JAK/STAT signaling. Genes Dev 13, 134253.
Zelzer, E. and Shilo, B. Z. (2000). Cell fate choices in Drosophila tracheal
morphogenesis. Bioessays 22, 219-26.
Zhang, J. G., Farley, A., Nicholson, S. E., Willson, T. A., Zugaro, L. M., Simpson, R.
J., Moritz, R. L., Cary, D., Richardson, R., Hausmann, G. et al. (1999). The
conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and
C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci U S A
96, 2071-6.
Zhang, Z., Schaffer, A. A., Miller, W., Madden, T. L., Lipman, D. J., Koonin, E. V.
and Altschul, S. F. (1998). Protein sequence similarity searches using patterns as seeds.
Nucleic Acids Res 26, 3986-90.

146

Vita
DATE OF BIRTH
January 13, 1974
PLACE OF BIRTH
San Antonio, Texas
EDUCATION
Bachelor of Science, cum laude (1996)
Furman University
EMPLOYMENT
Part-time Instructor (2004)
Biology Program, Transylvania University
Teaching/ Research Assistant (1998-2003)
Department of Biology, University of Kentucky
AWARDS AND CERTIFICATES
Vanderbilt University Kennedy Center Postdoctoral fellowship (2004, declined)
Vanderbilt University Neurogenomics Training Grant Postdoctoral fellowship
(2004, declined)
Graduate School Academic Year non-service fellowship (2001, 1998)
University of Kentucky Bioinformatics Certificate (2000)
Commandant’s List, U.S. Army Officer Basic Course (2000)
Gertrude Flora Ribble Graduate Research Scholarship (1999)
Daughters of the American Revolution Medal (1996)
Four-year Army ROTC Scholarship (1992)
PUBLICATIONS
J.S. Rawlings, K.M. Rosler, and D.A. Harrison. (2004) The JAK/STAT
Signaling Pathway. Journal of Cell Science 117, 1281-1283.
J.S. Rawlings, G. Rennebeck, S.M.W. Harrision, R. Xi, and D.A. Harrison.
(submitted) Two Suppressors of Cytokine Signaling (SOCS) differentially
regulate JAK and EGFR pathway activities.

147

